nitrates has been researched along with Angina Pectoris in 633 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
Angina Pectoris: The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
Excerpt | Relevance | Reference |
---|---|---|
"To evaluate the effects of add-on treatment with trimetazidine, single dose and long-term, on clinical and objective parameters of ischemia in patients with stable angina pectoris receiving standard antianginal therapy." | 9.10 | Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris. ( Almazov, VV; Kazarin, VV; Nifontov, EM; Rudomanov, OG; Shlyakhto, EV; Vakhrameyeva, IV; Vakhrameyeva, NV; Zakharov, DV, 2002) |
"The study was undertaken to evaluate whether the effect of combined amlodipine and atenolol therapy on patients with stable angina pectoris and with ST-depression during exercise testing and 48-h ambulatory electrocardiographic monitoring is superior to that of either agent given alone." | 9.09 | Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris. ( Ekdahl, S; Karlson, BW; Pehrsson, SK; Persson, S; Ringqvist, I; Ulvenstam, G, 2000) |
"Although the combined administration of atenolol and nifedipine has been shown to be effective in the treatment of angina pectoris the optimum dosage level of the combination has not yet been established." | 9.08 | A cross-over study comparing the efficacy of a combination of atenolol and nifedipine at different doses in angina pectoris. ( Jennings, K; Metcalfe, MJ, 1995) |
"In a randomized, cross-over, double-blind study, the effects of nifedipine were compared with those of diltiazem in 20 patients with severe stable angina pectoris and multivessel coronary artery disease treated with nitrates and beta-blockers." | 9.07 | Effects of nifedipine and diltiazem on myocardial ischemia in patients with severe stable angina pectoris treated with nitrates and beta-blockers. ( Meluzín, J; Simek, P; Stĕtka, F; Zeman, K, 1992) |
"To characterize the potential of nifedipine in the therapy of unstable angina pectoris we implemented a blinded, randomly assigned, titrated schedule of conventional therapy (propranolol, if not contraindicated, and isosorbide dinitrate) or nifedipine for 14 days in 126 patients hospitalized in a coronary care unit for ischemic chest pain of less than 45 min duration." | 9.05 | Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison. ( Morrison, J; Muller, JE; Pearle, DL; Rosner, B; Rude, RE; Schneider, JF; Serfas, DH; Sobel, BE; Stone, PH; Turi, ZG, 1984) |
"We studied the effect of a single oral dose of 40 mg of pentaerythritol tetranitrate (PETN) on the exercise capacity of ten patients with angina pectoris." | 9.05 | The prolonged effect of pentaerythritol tetranitrate on exercise capacity in stable effort angina pectoris. ( Giles, TD; Iteld, BJ; Mautner, RK; Quiroz, AC, 1981) |
"In the treatment of angina pectoris a double-blind evaluation of verapamil (Cordilox) at two dose levels-namely, 80 mg thrice daily and 120 mg thrice daily-propranolol (Inderal) 100 mg thrice daily, and isosorbide dinitrate (Vascardin) 20 mg thrice daily has been made against a placebo." | 9.04 | Double-blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris. ( Campbell, RC; Catley, PF; Livesley, B; Oram, S, 1973) |
"Organic nitrates have been used in the treatment of angina pectoris for over a century." | 8.80 | [Is it worthwhile to treat stable angina pectoris with long-acting nitrates?]. ( Kośmicki, M, 2000) |
"Nitrates have been periodically controversial since their introduction in 1867 as a treatment for angina pectoris." | 8.79 | [Characteristics of angina pectoris therapy with nitrates]. ( Silber, S, 1996) |
"This review discusses the mechanisms of action of the organic nitrates, nitrate tolerance, and the effects of nitrates in patients with stable angina pectoris." | 8.78 | Nitrates and angina pectoris. ( Parker, JO, 1993) |
"Nitrates are used extensively for the treatment of angina pectoris." | 8.78 | Role of nitrates in angina pectoris. ( Thadani, U, 1992) |
"Numerous controlled studies have shown that nitrates, beta blockers, and calcium antagonists are effective in the treatment of stable angina pectoris." | 8.77 | The role of nitrates, beta blockers, and calcium antagonists in stable angina pectoris. ( Askenase, A; Chan, PK; Garibian, G; Heo, JY; Iskandrian, AS; Segal, BL, 1988) |
"Nitroglycerin has maintained its position in the treatment of angina pectoris for more than a century." | 8.77 | Efficacy of different forms of nitrates in angina pectoris. ( Luomanmäki, K, 1985) |
" Appropriate dosing regimens of controlled-release formulations of isosorbide dinitrate (ISDN) and controlled-release NTG during long-term therapy have not been established." | 7.77 | Short and long-acting oral nitrates for stable angina pectoris. ( Lipicky, RJ; Thadani, U, 1994) |
"Nitrates are effective in the management of exertional angina pectoris primarily due to their peripheral effects i." | 7.67 | Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance. ( Thadani, U, 1984) |
"Combined nitrate/beta-blocker/nifedipine therapy is commonly used to treat refractory angina pectoris." | 7.67 | Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris. ( Boden, WE; Bough, EW; Korr, KS, 1985) |
" The most frequent adverse events were visual symptoms and sinus bradycardia with ivabradine (0." | 6.73 | Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial. ( Ford, I; Fox, KM; Ruzyllo, W; Tendera, M, 2007) |
"In patients with congestive heart failure, 1 hour after administration of 4 mg of molsidomine there were significant reductions in systolic and diastolic pulmonary artery pressures of 25% and 30%, respectively." | 6.66 | Effectiveness of molsidomine in the long-term treatment of exertional angina pectoris and chronic congestive heart failure. ( Dirschinger, J; Rudolph, W, 1985) |
" Although the total numbers of adverse events with each antianginal drug were similar, heart rate and blood pressure were significantly decreased by calcium antagonists but not changed by nicorandil (8." | 6.46 | [Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of β-blockers, nitrates and calcium antagonists]. ( Hanai, Y; Hishinuma, S; Mita, M; Shoji, M, 2010) |
" Simple, well-designed dosing schedules can avoid tolerance and rebound phenomena and can improve patient compliance." | 5.29 | The rationale for nitrates in angina pectoris. ( Held, P; Olsson, G, 1995) |
" Isosorbide 5-mononitrate appears at least as effective as the same dosage of isosorbide dinitrate and is probably superior to the calcium antagonists." | 5.27 | Mononitrates as monotherapy in the prophylactic treatment of angina pectoris. ( Aberg, A; Aström, H; Carlens, P; Lindström, E; Lundman, T; Nordlander, R; Nyberg, G; Rehnqvist, N; Ulvenstam, G, 1987) |
" Although the safety profile of nifedipine has been generally regarded as favorable, a few reports of clinically significant adverse effects in specific patient groups have appeared in the literature." | 5.26 | Nifedipine therapy in angina pectoris: evaluation of safety and side effects. ( Terry, RW, 1982) |
"A randomized single blind cross-over trial with placebo lead-in has been conducted in 71 anginal patients with arterial hypotension (group 1) and 38 ischemic heart disease patients with normal arterial pressure (group 2) to compare efficacy of therapy with isosorbide dinitrate (ID), sustac-forte (SF), isosorbide dinitrate retard (IDR) and trinitrolong (TN)." | 5.10 | [Nitrates in therapy of effort angina in hypotensive patients]. ( Borovkova, NV; Chernov, VI; Demochko, AV; Idrisova, EM; Karpov, RS; Kladieva, EA; Shishkina, AA; Vorob'eva, EV, 2003) |
"To evaluate the effects of add-on treatment with trimetazidine, single dose and long-term, on clinical and objective parameters of ischemia in patients with stable angina pectoris receiving standard antianginal therapy." | 5.10 | Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris. ( Almazov, VV; Kazarin, VV; Nifontov, EM; Rudomanov, OG; Shlyakhto, EV; Vakhrameyeva, IV; Vakhrameyeva, NV; Zakharov, DV, 2002) |
"The study was undertaken to evaluate whether the effect of combined amlodipine and atenolol therapy on patients with stable angina pectoris and with ST-depression during exercise testing and 48-h ambulatory electrocardiographic monitoring is superior to that of either agent given alone." | 5.09 | Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris. ( Ekdahl, S; Karlson, BW; Pehrsson, SK; Persson, S; Ringqvist, I; Ulvenstam, G, 2000) |
"Although the combined administration of atenolol and nifedipine has been shown to be effective in the treatment of angina pectoris the optimum dosage level of the combination has not yet been established." | 5.08 | A cross-over study comparing the efficacy of a combination of atenolol and nifedipine at different doses in angina pectoris. ( Jennings, K; Metcalfe, MJ, 1995) |
" In the present study we examined the effects of digitalis, beta-adrenergic blockers, slow release nitrates, calcium channel blockers, presence of arterial hypertension (AHT), and angiocardiographic changes on the exercise ECG variables." | 5.07 | Effects of digitalis, anti-anginal drugs and arterial hypertension on the relationships between exercise ECG and angiocardiographic variables and on the diagnostic accuracy of exercise ECG in patients with coronary heart disease. ( Backman, C; Jacobsson, KA; Linderholm, H; Osterman, G, 1994) |
"In a randomized, cross-over, double-blind study, the effects of nifedipine were compared with those of diltiazem in 20 patients with severe stable angina pectoris and multivessel coronary artery disease treated with nitrates and beta-blockers." | 5.07 | Effects of nifedipine and diltiazem on myocardial ischemia in patients with severe stable angina pectoris treated with nitrates and beta-blockers. ( Meluzín, J; Simek, P; Stĕtka, F; Zeman, K, 1992) |
"The Nifedipine-Total Ischemia Awareness Program was designed to evaluate the prevalence, prognostic implications and effect of therapy on painful and painless myocardial ischemic episodes in a nationwide study of patients with angina pectoris." | 5.06 | The Nifedipine-Total Ischemia Awareness Program: a national survey of painful and painless myocardial ischemia including results of antiischemic therapy. ( Cohn, PF; Gerber, FR; Nesto, R; Vetrovec, GW, 1989) |
"The treatment of 15 patients with coronary heart disease and exertion-related angina pectoris with isosorbide dinitrate (ISDN) tablets in 4 doses (6 X 5 mg, 6 X 20 mg, 6 X 40 mg, 6 X 80 mg) in a randomized sequence for 1 week each resulted in a dose-related improvement of ischemia (ST-segment depression during stress testing) as compared to placebo: 5 mg (30 mg/day): 24% (p less than 0." | 5.06 | [Dose-response relationship of nitrate therapy of angina pectoris]. ( Kaltenbach, M; Schneider, W, 1986) |
"Kuanxiong Aerosol (KA) has been used in patients with angina pectoris (AP) attacks for many years, this systematic review and meta-analysis aims to evaluate the clinical efficacy and safety of KA versus nitrates in the treatment of AP." | 5.05 | A meta-analysis for Kuanxiong Aerosol on the treatment of angina pectoris. ( Cai, H; Chen, B; Chen, Y; Dai, X; Jin, Z; Zhang, H; Zhong, L; Zhuang, J, 2020) |
"To characterize the potential of nifedipine in the therapy of unstable angina pectoris we implemented a blinded, randomly assigned, titrated schedule of conventional therapy (propranolol, if not contraindicated, and isosorbide dinitrate) or nifedipine for 14 days in 126 patients hospitalized in a coronary care unit for ischemic chest pain of less than 45 min duration." | 5.05 | Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison. ( Morrison, J; Muller, JE; Pearle, DL; Rosner, B; Rude, RE; Schneider, JF; Serfas, DH; Sobel, BE; Stone, PH; Turi, ZG, 1984) |
"We studied the effect of a single oral dose of 40 mg of pentaerythritol tetranitrate (PETN) on the exercise capacity of ten patients with angina pectoris." | 5.05 | The prolonged effect of pentaerythritol tetranitrate on exercise capacity in stable effort angina pectoris. ( Giles, TD; Iteld, BJ; Mautner, RK; Quiroz, AC, 1981) |
"To evaluate the effect of sublingual nitroglycerin (N) and chewable isosorbide dinitrate (I) in patients with angina pectoris, 12 subjects underwent treadmill exercise to the point of onset of angina." | 5.04 | Acute drug testing with nitrates: angina relief during treadmill exercise. ( Alimurung, B; Fletcher, GF; Watt, E, 1977) |
"In the treatment of angina pectoris a double-blind evaluation of verapamil (Cordilox) at two dose levels-namely, 80 mg thrice daily and 120 mg thrice daily-propranolol (Inderal) 100 mg thrice daily, and isosorbide dinitrate (Vascardin) 20 mg thrice daily has been made against a placebo." | 5.04 | Double-blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris. ( Campbell, RC; Catley, PF; Livesley, B; Oram, S, 1973) |
"Nitrates and nitrate-containing compounds are vasodilators used for the treatment of angina and heart failure." | 4.98 | A New Perspective on the Nitrate-Phosphodiesterase Type 5 Inhibitor Interaction. ( Goggin, P; Goldstein, I; Hackett, G; Kirby, MG; Kloner, RA; Osterloh, I; Parker, JD; Sadovsky, R, 2018) |
"Short-acting nitrates are beneficial in acute myocardial ischemia." | 4.91 | Use of nitrates in ischemic heart disease. ( Giuseppe, C; Hans-Ulrich, I; Paul, J, 2015) |
" For symptomatic treatment and prevention of angina pectoris, beta-blockers, calcium channel blockers, nitrates, I((f)) (funny channel) blockers and ranolazine are effective." | 4.88 | [Conservative therapy of patients with stable coronary heart disease]. ( Custodis, F; Laufs, U, 2012) |
" Strategies used for plaque stabilisation resulting in a reduction in cardiovascular mortality and morbidity are: smoking cessation; aspirin (acetylsalicylic acid); blood pressure control; lipid lowering agents when low density lipoprotein cholesterol is elevated despite dietary therapy; coronary bypass surgery in patients with left main stem disease or triple vessel coronary disease and diminished left ventricular function; and use of estrogen in postmenopausal women." | 4.80 | Choosing the most appropriate treatment for stable angina. Safety considerations. ( Asirvatham, S; Sebastian, C; Thadani, U, 1998) |
"Organic nitrates have been used in the treatment of angina pectoris for over a century." | 4.80 | [Is it worthwhile to treat stable angina pectoris with long-acting nitrates?]. ( Kośmicki, M, 2000) |
"Glyceryl trinitrate, isosorbide dinitrate, and isosorbide-5-mononitrate are organic nitrate esters commonly used in the treatment of angina pectoris, myocardial infarction, and congestive heart failure." | 4.79 | Mechanisms of action of nitrates. ( Ahlner, J; Torfgård, KE, 1994) |
"There is now little dispute that clinical tolerance of organic nitrates occurs, particularly when these drugs are used by themselves to treat patients with stable angina pectoris and congestive heart failure." | 4.79 | Mechanisms of nitrate tolerance. ( Bauer, JA; Fung, HL, 1994) |
"Nitrates have been periodically controversial since their introduction in 1867 as a treatment for angina pectoris." | 4.79 | [Characteristics of angina pectoris therapy with nitrates]. ( Silber, S, 1996) |
"The efficacy of organic nitrates in the treatment of acute episodes of angina pectoris is unquestioned." | 4.78 | Nitrate therapy and the development of tolerance. ( Thadani, U, 1993) |
"Although organic nitrates have been used in the treatment of patients with angina pectoris for more than 100 years, their mechanism of action was only disclosed during the last years." | 4.78 | [Nitrogen monoxide (NO)--the active principle of organic nitrates]. ( Feelisch, M, 1993) |
"This review discusses the mechanisms of action of the organic nitrates, nitrate tolerance, and the effects of nitrates in patients with stable angina pectoris." | 4.78 | Nitrates and angina pectoris. ( Parker, JO, 1993) |
"Nitrates are used extensively for the treatment of angina pectoris." | 4.78 | Role of nitrates in angina pectoris. ( Thadani, U, 1992) |
" Nitrates have a place in the prophylactic treatment of patients with angina pectoris." | 4.78 | Prophylactic nitrate therapy in angina pectoris--is there an optimal treatment regimen? ( Allgén, J; Olsson, G, 1992) |
"Nitrates have a place in the prophylactic treatment of patients with angina pectoris." | 4.78 | Is there an optimal prophylactic nitrate therapy? ( Allgén, J; Olsson, G, 1991) |
"The organic nitrates are effective agents in the management of patients with angina pectoris." | 4.78 | Nitrate tolerance. A problem during continuous nitrate administration. ( Parker, JO, 1990) |
"Nitrates are highly effective both in terminating acute attacks of angina pectoris and in the prophylaxis of symptomatic and asymptomatic myocardial ischemia." | 4.78 | Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate. ( Silber, S, 1990) |
" The dilatation of veins induced by nitrates explains also their effectiveness in patients suffering from heart failure with high left ventricular pressure." | 4.78 | [Current status of pharmacology and therapeutic use of nitro derivatives]. ( Costa, R; Marino, A, 1990) |
"Nitrates are old drugs, introduced into medical treatment more than 100 years ago, initially as a homeopathic remedy against headache (1850), and only later against angina pectoris (1867)." | 4.77 | [The mechanism of action of nitrates, 1988 status]. ( Lichtlen, PR, 1989) |
"Numerous controlled studies have shown that nitrates, beta blockers, and calcium antagonists are effective in the treatment of stable angina pectoris." | 4.77 | The role of nitrates, beta blockers, and calcium antagonists in stable angina pectoris. ( Askenase, A; Chan, PK; Garibian, G; Heo, JY; Iskandrian, AS; Segal, BL, 1988) |
"The choice between beta-blockers, long-acting nitrates, and calcium antagonists for prophylactic treatment of stable angina pectoris is determined by several factors, including specific indications for and contraindications to a particular drug." | 4.77 | Combination of nitrates with other antianginal drugs. ( Andersson, KE; Hoglund, P, 1987) |
"Nitrates are vasodilators of venous and arterial smooth muscle commonly prescribed both for angina and congestive heart failure." | 4.77 | Nitrate therapy in angina and congestive heart failure. ( Cohn, PF; Vlay, SC, 1985) |
"Nitrates are presently used in the therapy for angina pectoris." | 4.77 | Nitrate therapy for angina pectoris. Current concepts about mechanism of action and evaluation of currently available preparations. ( Corwin, S; Reiffel, JA, 1985) |
"Nitroglycerin has maintained its position in the treatment of angina pectoris for more than a century." | 4.77 | Efficacy of different forms of nitrates in angina pectoris. ( Luomanmäki, K, 1985) |
"The effectiveness of organic nitrates in the therapy of angina pectoris can be explained from their direct relaxing action on vascular smooth muscle." | 4.76 | [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation]. ( Bassenge, E; Busse, R, 1982) |
"Nitroglycerin has been the mainstay of the medical management of angina pectoris for over 100 years." | 4.76 | The transdermal administration of nitrates: an overview. ( Demma, FJ; Wilson, RR, 1983) |
" Nitrates are routinely used for the treatment of stable and unstable angina and also play a role in therapy for complications of myocardial infarction." | 4.76 | Nitrate delivery systems in perspective. A decade of progress. ( Abrams, J, 1984) |
"The expanding applications of nitroglycerin and nitrate esters--in congestive heart failure, in the reduction of infarct size in myocardial infarction and in the long-term prophylaxis of angina--have enhanced the clinical importance of these drugs." | 4.75 | Nitroglycerin and nitrate esters. ( Francis, GS; Warren, SE, 1978) |
"Nitrates are one of the most prescribed medications in the treatment of angina pectoris today." | 4.31 | The Relationship Between Nitrate-Induced Headache and -Blood Viscosity: An Observational Prospective Study. ( Biçer, A; Demirbağ, R; Erdoğdu, H; İnanır, M; Kaplangöray, M; Memioglu, T; Toprak, K, 2023) |
" Using data from the Global Registry of Acute Coronary Events (GRACE) and Canadian Registry of Acute Coronary Events (CANRACE), we examined the temporal trends in antianginal use (beta blockers, calcium antagonists, and nitrates) before non-ST-elevation acute coronary syndrome presentation from 1999 to 2008 in 10,019 patients." | 3.79 | Management and outcomes of non-ST elevation acute coronary syndromes in relation to previous use of antianginal therapies (from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]). ( Fitchett, D; Goodman, SG; Graham, JJ; Kang, JS; Lopez-Sendon, J; Pesant, Y; Rose, BF; Spencer, FA; Wong, GC; Yan, AT; Yan, RT, 2013) |
" Appropriate dosing regimens of controlled-release formulations of isosorbide dinitrate (ISDN) and controlled-release NTG during long-term therapy have not been established." | 3.77 | Short and long-acting oral nitrates for stable angina pectoris. ( Lipicky, RJ; Thadani, U, 1994) |
"Nitrates are one of the most commonly prescribed drug groups for cardiac disease, especially for angina pectoris and congestive heart failure." | 3.71 | Appropriateness of nitrate use in a general medicine population. ( Hadari, R; Kovatz, S; Qasim, M; Shenkman, L; Shilo, L, 2001) |
" In patients with stable angina pectoris (SAP), we have observed a similar phenomenon: decreased platelet response to disaggregating effects of nitroglycerin (NTG) and sodium nitroprusside (SNP)." | 3.70 | Nitrate resistance in platelets from patients with stable angina pectoris. ( Chirkov, YY; Chirkova, LP; Holmes, AS; Horowitz, JD, 1999) |
" These eight men and two women, aged 58 +/- 5 years, with extensive three-vessel coronary disease and ejection fractions of 40% +/- 5%, had New York Heart Association (NYHA) class IV angina despite medical therapy, including nitrates, beta-blockade, calcium channel blockade, and narcotics." | 3.69 | Treatment of medically and surgically refractory angina pectoris with high thoracic epidural analgesia: initial clinical experience. ( Gramling-Babb, P; Miller, MJ; Reeves, ST; Roy, RC; Zile, MR, 1997) |
"Nitrates, molsidomin, betablockers, calcium antagonists, inhibitors of platelet aggregation and anticoagulants are the most important drugs for the management of the different forms of angina pectoris." | 3.68 | [Anti-ischemia drug therapy]. ( Dubach, P; Ratti, R, 1991) |
"The number of drugs available for treatment of angina pectoris has increased dramatically in recent years; new beta and calcium channel blockers are to be introduced; nitrates are now available in transdermal pads and could become released as buccal tablets or aerosol sprays." | 3.67 | Medical management of stable angina pectoris. ( Harris, PJ, 1984) |
"To determine if ordinary doses of nitrates produce a significant increase in methemoglobin, methemoglobin levels were measured in 59 randomly selected patients with coronary artery disease and unstable angina pectoris who were receiving organic nitrate therapy." | 3.67 | Methemoglobin levels produced by organic nitrates in patients with coronary artery disease. ( Arsura, E; Greengart, A; Guadagnino, V; Hollander, G; Lichstein, E; Nicchi, V; Sanders, M, 1984) |
"Nitrates are effective in the management of exertional angina pectoris primarily due to their peripheral effects i." | 3.67 | Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance. ( Thadani, U, 1984) |
"Fifteen patients with coronary heart disease and stable angina pectoris of effort were examined for tolerance to the antianginal effect of isosorbide dinitrate (ID) taken permanently." | 3.67 | [Tolerance for the antianginal effect of nitrates. Approaches to its study]. ( Martsevich, SIu; Metelitsa, VI; Shakarova, SSh; Strel'tsov, AA; Vygodin, VA, 1984) |
" Age, sex, left ventricular ejection fraction, and nitrates and diltiazem used for the treatment of angina pectoris did not affect the daily profile of VPC prevalence in any patient groups." | 3.67 | The daily profile of ventricular premature beats in the patients with ischemic heart disease. ( Haraoka, S; Matsuno, S; Saito, D, 1987) |
"Combined nitrate/beta-blocker/nifedipine therapy is commonly used to treat refractory angina pectoris." | 3.67 | Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris. ( Boden, WE; Bough, EW; Korr, KS, 1985) |
"To assess the efficacy of long-term diltiazem therapy when added to beta blockers and nitrates, we prospectively studied patients with chronic exertional angina who were determined to have medically refractory angina pectoris which was too severe to enter placebo-controlled studies." | 3.67 | Efficacy of diltiazem for medically refractory stable angina: long-term follow-up. ( Beier-Scott, L; Bristow, MR; Ginsburg, R; McAuley, BJ; Schroeder, JS, 1985) |
"Standard single doses of nitrates, Ca-antagonists and beta-adrenoblockers were studied and compared in 37 patients presenting with stable angina pectoris of effort by repeated treadmill tests coupled with ECG monitoring." | 3.67 | [Screening of single doses of nitrates, calcium antagonists and beta-adrenoblockaders in patients with stenocardia of effort by using pharmacodynamic treadmill studies]. ( Martsevich, SIu; Metelitsa, VI; Slastnikova, ID, 1985) |
"The charts of patients initially treated with long-acting oral or ointment (LAOO) nitrate therapy who subsequently used transdermal nitroglycerin (TNG) patches for the treatment of angina pectoris were reviewed to evaluate patient response, cost-effectiveness, and therapy preference." | 3.67 | Comparison of transdermal nitroglycerin therapy with previous long-acting oral or ointment nitrate therapy. ( Chinoy, DA, 1987) |
"Verapamil is effective primary therapy for angina pectoris at a dosage of about 120 mg three times a day." | 3.66 | Calcium channel blocking drugs for chronic, stable angina. Verapamil. ( Kelly, DT, 1982) |
"The effects of a newly developed nicotinamide derivative, N-(2-hydroxyethyl)nicotinamide nitrate (SG-75, Nicorandil), were examined in an experimental model of angina pectoris, utilizing methacholine-induced ECG changes as main parameter in intact anesthetized rats." | 3.66 | Effects of N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) on methacholine-induced ECG changes in intact anesthetized rats. ( Akima, M; Aono, J; Sakai, K, 1981) |
"Nitroglycerin should be the first agent prescribed for patients with angina pectoris." | 3.65 | Medical management of angina pectoris. ( Kotler, MN; Likoff, W; Segal, BL, 1977) |
"Nicorandil (NCO) is an antianginal agent first discovered in the late 1970s with a uniquely dual mechanism of action." | 3.01 | Cardioprotective and Antianginal Efficacy of Nicorandil: A Comprehensive Review. ( Carey, M; Elshaikh, A; Goel, H; Goyal, D; Krinock, M; Nadar, SK, 2023) |
"Depression is a risk factor for the development of coronary heart disease but the relationship between coronary endothelial dysfunction and depression is not yet known." | 2.75 | Coronary endothelial dysfunction associated with a depressive mood in patients with atypical angina but angiographically normal coronary artery. ( Choi, CU; Kim, EJ; Kim, JH; Kim, JW; Ko, YH; Na, JO; Oh, DJ; Park, CG; Rha, SW; Seo, HS, 2010) |
" The most frequent adverse events were visual symptoms and sinus bradycardia with ivabradine (0." | 2.73 | Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial. ( Ford, I; Fox, KM; Ruzyllo, W; Tendera, M, 2007) |
" After a 10- to 21-day washout period, subjects crossed over to either placebo or tadalafil, and nitrate dosing was repeated." | 2.71 | Time course of the interaction between tadalafil and nitrates. ( Denne, J; Emmick, JT; Hutter, AM; Jackson, G; Kloner, RA; Mitchell, MI, 2003) |
"Four weeks of treatment with trimetazidine in combination with conventional antiangina drugs leads to a longer delay to development of 1 mm ST depression (ischemia threshold), significant lengthening of total duration of treadmill exercise, increased total work, and longer delay to angina theshold." | 2.69 | [Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study]. ( Domzal-Bochenska, M; Elikowski, W; Gajos, G; Kaluza, G; Kulon, I; Kuźniak, M; Pachocki, R; Paradowski, A; Szwed, H; Szydlowski, Z; Szymczak, K; Wator-Brzezińska, A, 2000) |
" Both the dosage forms of nitroglycerin administered in the effective amounts (in short- and long-term continuous treatment) significantly lowered the rate and total intensity of myocardial ischemia episodes at the expense of a significant decrease of the frequency and total intensity of PE." | 2.67 | [An assessment of the efficacy of a course of using different forms of prolonged-action nitrates in patients with stable stenocardia with the help of repeated daily ECG monitoring]. ( Bochkareva, EV; Kokurina, EV; Metelitsa, VI; Vodop'ianova, RS, 1990) |
"Diltiazem or placebo was administered according to a double-blind design, with randomized cross-over at the end of each 2 week treatment period." | 2.66 | Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study. ( Boden, WE; Bough, EW; Korr, KS; Reichman, MJ; Rich, VB; Shulman, RS; Young, PM, 1985) |
"We conclude that patients with unstable angina pectoris have a similar outcome after two years whether they receive medical therapy alone or coronary bypass surgery plus medical therapy." | 2.66 | Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study. ( Deupree, RH; Luchi, RJ; Scott, SM, 1987) |
"The hemodynamic and antianginal effects of 30 mg of isosorbide dinitrate (ISDN) were assessed in 12 patients with chronic stable angina after initial dosing and after 7 to 10 days of therapy four times daily." | 2.66 | Nitrate tolerance: the lack of effect of N-acetylcysteine. ( Farrell, B; Lahey, KA; Parker, JO; Rose, BF, 1987) |
"In patients with congestive heart failure, 1 hour after administration of 4 mg of molsidomine there were significant reductions in systolic and diastolic pulmonary artery pressures of 25% and 30%, respectively." | 2.66 | Effectiveness of molsidomine in the long-term treatment of exertional angina pectoris and chronic congestive heart failure. ( Dirschinger, J; Rudolph, W, 1985) |
"Chronic angina pectoris is associated with considerable morbidity and mortality, especially if treated suboptimally." | 2.55 | Antianginal Therapy for Stable Ischemic Heart Disease: A Contemporary Review. ( Boden, WE; Cabral, KP; Lavelle, MP; Morrone, D; Padala, SK; Sidhu, MS; Toth, PP, 2017) |
"It is important to know how to treat hypertension in patients with coronary artery disease (CAD)." | 2.53 | Current treatment of hypertension in patients with coronary artery disease recommended by different guidelines. ( Aronow, WS, 2016) |
" While their efficacy in relieving angina pectoris symptoms in acute settings and in preventing angina before physical or emotional stress is undisputed, the chronic use of nitrates has been associated with potentially important side effects such as tolerance and endothelial dysfunction." | 2.52 | Beta-Blockers and Nitrates: Pharmacotherapy and Indications. ( Bongo, AS; Cavallino, C; Degiovanni, A; Facchini, E; Lupi, A; Rognoni, A, 2015) |
" Although the total numbers of adverse events with each antianginal drug were similar, heart rate and blood pressure were significantly decreased by calcium antagonists but not changed by nicorandil (8." | 2.46 | [Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of β-blockers, nitrates and calcium antagonists]. ( Hanai, Y; Hishinuma, S; Mita, M; Shoji, M, 2010) |
"Ivabradine is a new selective HR-lowering agent that selectively inhibits the pacemaker current I (f) in the sinus atrial node." | 2.45 | Ivabradine: beyond heart rate control. ( D'Orazio, N; Riccioni, G; Vitulano, N, 2009) |
"Angina pectoris affects at least 6." | 2.43 | Current strategies for the prevention of angina in patients with stable coronary artery disease. ( Bhatt, AB; Stone, PH, 2006) |
"Nitrates rarely cause coronary steal and myocardial ischaemia." | 2.43 | Side effects of using nitrates to treat angina. ( Rodgers, T; Thadani, U, 2006) |
"Ivabradine (Procoralan) is a selective and specific I(f) inhibitor that acts on one of the most important ionic currents for the regulation of the pacemaker activity of sinoatrial node cells." | 2.43 | Heart rate slowing versus other pharmacological antianginal strategies. ( Diaz, A; Tardif, JC, 2006) |
" In these patients, beneficial antianginal and antiischemic effects of nitrates for 10-14 hours during the daytime can be maintained by using formulations and dosing regimens that avoid or minimize the development of tolerance (standard formulation of isosorbide-5-mononitrate, 20 mg in the morning and 7 hours later; slow-release formulation of isosorbide-5-mononitrate, 120-240 mg once a day; or nitroglycerin patch delivering 0." | 2.40 | Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure. ( Thadani, U, 1997) |
" There is substantial evidence that this can be prevented by an adequate nitrate-free or nitrate-low period during each 24 h dosing interval." | 2.40 | Optimal nitrate therapy with a once-daily sustained-release formulation of isosorbide mononitrate. ( Waller, DG, 1999) |
" Isosorbide 5-mononitrate has been studied in its own right as an antianginal agent: it is completely absorbed after oral administration; it has a half-life of around 4 hours, and oral standard and controlled-release formulations have been extensively studied." | 2.39 | Clinical pharmacokinetics of nitrates. ( Bogaert, MG, 1994) |
" Conducive to tolerance are obviously continuous application, short dosing intervals and high-dosage level so that an anti-ischaemic protection or rather, for heart insufficiency a haemodynamic relief, cannot be achieved by using organic nitrates around the clock." | 2.39 | [Controlled clinical studies of tolerance development and dosing problems in nitrate therapy]. ( Abshagen, U, 1996) |
" I believe that this problem can be avoided with well-designed dosing regimens." | 2.38 | Use of nitrates in ischemic heart disease. ( Abrams, J, 1992) |
"Tolerance develops during therapy with all organic nitrates, particularly when dosing strategies are designed to provide therapeutic effects throughout 24 h." | 2.38 | Nitrate tolerance--can it be prevented? ( Parker, JO, 1991) |
"Nitrates are a reasonable choice." | 2.38 | Individualized antianginal therapy guided by systemic arterial pressure. ( Reisin, L; Schneeweiss, A, 1990) |
"Unstable angina is a clinical syndrome characterized by increased rate and severity of angina pectoris attacks and, sometimes but not always, accompanied by ECG changes similar to those seen in coronary insufficiency." | 2.38 | Unstable angina: pathophysiology and drug therapy. ( Bleifeld, W, 1990) |
" Tolerance occurs with any dosing regimen that results in nitrate accumulation in the plasma or nearly-constant plasma concentrations, as is the case with multiple daily doses of oral nitrates or continuous application of transdermal patch systems." | 2.38 | Nitrate therapy in patients with coronary artery disease--preparations and doses with and without development of tolerance. ( Dirschinger, J; Hall, D; Kraus, F; Reiniger, G; Rudolph, W, 1990) |
" Dosing strategies designed to provide therapeutic plasma nitrate concentrations throughout the 24 hours of the day are regularly associated with the development of tolerance." | 2.38 | Nitrate tolerance in angina pectoris. ( Parker, JO, 1989) |
"Unstable angina is an acute coronary syndrome characterized by the rapid progression of clinical symptoms which may culminate in acute myocardial infarction, infarct extension or sudden death." | 2.38 | Postinfarction unstable angina. Pathophysiologic basis for current treatment modalities. ( Alpert, JS; Becker, RC; Gore, JM, 1989) |
" Dosing regimens with documented effectiveness in long-term controlled studies are available for both isosorbide dinitrate and isosorbide 5-mononitrate as well as for transdermal nitroglycerin systems." | 2.38 | [Long-term therapy with nitrates. How can continuous effectiveness be achieved?]. ( Beyerle, A; Dirschinger, J; Reiniger, G; Rudolph, W, 1989) |
" An alternate dosing mode is proposed that speculatively may provide an improvement in producing and maintaining nitrate action in long-term angina therapy." | 2.37 | Pharmacokinetic determinants of nitrate action. ( Fung, HL, 1984) |
" New nitrate delivery systems have recently become available which provide considerable dosing flexibility, further increasing the interest in this group of compounds." | 2.37 | Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration. ( Abrams, J, 1987) |
"Unstable angina is a clinical syndrome that includes patients with new onset of angina, a change in a previous stable pattern, or the development of chest pain at rest." | 2.37 | Use of nitrates in the treatment of unstable and variant angina. ( Nordlander, R, 1987) |
" It is appropriate that the patient's dosage of nitrates be administered with a formulation most likely to be both clinically effective and well tolerated." | 2.37 | Pharmacology of nitroglycerin and long-acting nitrates. ( Abrams, J, 1985) |
"Nitrates have been widely used as anti-ischemic drugs in CAS patients, while it is not recommended in MB patients." | 1.91 | Prognostic impact of nitrate therapy in patients with myocardial bridge and coexisting coronary artery spasm. ( Choi, BG; Kim, JB; Rha, SW, 2023) |
"Diltiazem alone was not an independent predictor for major adverse cardiovascular events or recurrent angina requiring repeat coronary angiography." | 1.46 | Impact of Diltiazem Alone versus Diltiazem with Nitrate on Five-Year Clinical Outcomes in Patients with Significant Coronary Artery Spasm. ( Byun, JK; Choi, BG; Choi, CU; Choi, JY; Choi, SY; Kim, EJ; Kim, JW; Lee, JJ; Lee, S; Lim, HE; Na, JO; Oh, DJ; Park, CG; Park, EJ; Park, JY; Park, SH; Park, T; Rha, SW; Seo, HS, 2017) |
"Ivabradine was shown to be as effective as well-established reference antianginal drugs, such as beta-blockers and calcium antagonists." | 1.33 | Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina. ( Fox, K, 2006) |
"Clinical and device evaluation of efficacy of new dosage forms of isosorbide-5-mononitrate (ISMN) in patients with angina of effort of functional class (FC) II-III in 1-3 month treatment." | 1.32 | [Various forms of mononitrates in treating patients with stress angina]. ( Kazachkina, SS; Lupanov, VP; Naumov, VG, 2003) |
"Definite angina pectoris was present in 33, probable angina pectoris in 18, and possible angina pectoris in 19 subjects." | 1.32 | Repeated nitrate prescriptions as a potential marker for angina pectoris. A comparison with medical information from the Rotterdam Study. ( de Boer, A; Hofman, A; Klungel, OH; Leufkens, HG; Maitland-van der Zee, AH; Stricker, BH; van der Kuip, DA; Witteman, JC, 2003) |
"Two brothers had familial hypertrophic cardiomyopathy and vasospastic angina pectoris concurrently." | 1.32 | Coexistence of familial hypertrophic cardiomyopathy and vasospastic angina pectoris in two brothers. ( Hirano, H; Kawano, H; Koide, Y; Sato, O; Seto, S; Suzuki, N; Yano, K, 2003) |
" Simple, well-designed dosing schedules can avoid tolerance and rebound phenomena and can improve patient compliance." | 1.29 | The rationale for nitrates in angina pectoris. ( Held, P; Olsson, G, 1995) |
"Stable angina is usually due to coronary atherosclerosis and complicated by myocardial lesions responsible for ischaemic myocardiopathy." | 1.29 | [Medical treatment of patients with stable angina pectoris]. ( Carville, C; Castaigne, A; Chazouillères, AF; Scherrer-Crosbie, M, 1995) |
" The author discusses the action, indications, contraindications, undesirable effects, and average dosage of nitrates, beta-blockers, calcium channel inhibitors and antithrombotics." | 1.29 | [Antianginal therapy '95]. ( Stejfa, M, 1996) |
" Findings indicate that despite a higher unit cost for ISMO, total anticipated treatment costs with this new long-acting nitrate are lower than those associated with ISDN (28%) and nitroglycerin patch (16%) therapy in patients with stable angina, and ISMO requires less dosing titration and is associated with fewer tolerance effects." | 1.29 | Cost-effectiveness study of nitrate therapy using a decision analysis methodology. ( Larrat, EP, 1994) |
" The mechanism of action of different drugs, its indications, as well as the dosage and frequency of use are reviewed." | 1.28 | The treatment of stable angina pectoris. ( García-Palmieri, MR, 1992) |
" This oesophageal disorder may be considered a side effect caused by prolonged therapy with nitroderivatives and Ca-antagonists." | 1.28 | "Oesophageal angina" in patients with angina pectoris: a possible side effect of chronic therapy with nitroderivates and Ca-antagonists. ( Bacchelli, S; Barbara, L; Bortolotti, M; Brunelli, F; Degli Esposti, D; Del Campo, L; Labriola, E; Sarti, P, 1992) |
" For isosorbide dinitrate and isosorbide 5-mononitrate, as well as for transdermal nitroglycerin systems, interval treatment dosing regimens with maintained effectiveness documented in controlled studies have been delineated." | 1.28 | Effectiveness of interval nitrate therapy in angina pectoris. ( Bayeric, A; Dirschinger, J; Hall, D; Reiniger, G; Rudolph, W, 1989) |
"Sustonite, a long-acting nitroglycerin drug for oral use (manufactured in Poland), and some other dosage forms of nitrates were studied and compared." | 1.28 | [Evaluation of the antianginal efficacy of sustonit compared with other nitrate drug forms]. ( Kokurina, EV; Martsevich, SIu; Metelitsa, VI; Slastnikova, ID; Urumbaev, RK, 1989) |
" Of course, proper dosing must be determined for the individual patient by the physician." | 1.27 | Titrates for treatment of unstable angina pectoris and coronary vasospasm. ( Conti, RC; Feldman, RL; Hill, JA; Mehta, JL; Pepine, CJ, 1983) |
"Beta blockers are also effective in the treatment of angina pectoris, and despite their side effects, are particularly useful in effort angina." | 1.27 | Rational medical therapy for stable angina pectoris. ( Abrams, J; Hoekenga, D, 1984) |
"The treatment of unstable angina pectoris should take into account self-regulation, the possibilities for improved oxygen transport, and a reduction of myocardial oxygen requirement." | 1.27 | [Unstable angina pectoris]. ( Friedemann, M, 1984) |
"Only in rare cases with cardiac failure or with rapid atrial fibrillation glycosides will be necessary." | 1.27 | [Therapy of angina pectoris]. ( Sterz, H, 1984) |
"Drug therapy of angina pectoris and arrhythmias after myocardial infarction is basically the same as in patients without a history of infarction." | 1.27 | [Diagnosis and drug therapy in the postinfarct phase]. ( Kronik, G, 1984) |
" Isosorbide 5-mononitrate appears at least as effective as the same dosage of isosorbide dinitrate and is probably superior to the calcium antagonists." | 1.27 | Mononitrates as monotherapy in the prophylactic treatment of angina pectoris. ( Aberg, A; Aström, H; Carlens, P; Lindström, E; Lundman, T; Nordlander, R; Nyberg, G; Rehnqvist, N; Ulvenstam, G, 1987) |
" Although the safety profile of nifedipine has been generally regarded as favorable, a few reports of clinically significant adverse effects in specific patient groups have appeared in the literature." | 1.26 | Nifedipine therapy in angina pectoris: evaluation of safety and side effects. ( Terry, RW, 1982) |
"After treatment of ischemia and/or failure, specific antiarrhythmic agents, conventional and investigational, alone or in combination, are systematically selected." | 1.26 | Ventricular ectopy: etiology, evaluation, and therapy. ( Reid, PR; Vlay, SC, 1982) |
"Vasodilator treatment of congestive heart failure has provided an important new role for long-acting nitrates." | 1.26 | Nitrate tolerance and dependence. A critical assessment. ( Abrams, J, 1980) |
"Thus nifedipine appears to be an efficacious agent in the treatment of refractory rest angina in patients with obstructive coronary artery disease." | 1.26 | Efficacy of nifedipine in rest angina refractory to propranolol and nitrates in patients with obstructive coronary artery disease. ( Banka, VS; Bodenheimer, MM; Feldman, M; Helfant, RH; Moses, JW; Wertheimer, JH, 1981) |
" Although the dosage should be determined on an individual basis, the administration of a chewing tablet, containing 4 mg." | 1.24 | Anginal syndrome. Treatment with a long-acting nitrate (itramin tosylate). ( BATTERMAN, RC; MOURATOFF, GJ, 1963) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 394 (62.24) | 18.7374 |
1990's | 128 (20.22) | 18.2507 |
2000's | 65 (10.27) | 29.6817 |
2010's | 40 (6.32) | 24.3611 |
2020's | 6 (0.95) | 2.80 |
Authors | Studies |
---|---|
Kim, JB | 1 |
Choi, BG | 2 |
Rha, SW | 3 |
Goel, H | 1 |
Carey, M | 1 |
Elshaikh, A | 1 |
Krinock, M | 1 |
Goyal, D | 1 |
Nadar, SK | 1 |
Toprak, K | 1 |
Kaplangöray, M | 1 |
Memioglu, T | 1 |
İnanır, M | 1 |
Biçer, A | 1 |
Demirbağ, R | 1 |
Erdoğdu, H | 1 |
Zhuang, J | 1 |
Dai, X | 1 |
Zhang, H | 1 |
Chen, Y | 1 |
Cai, H | 1 |
Jin, Z | 1 |
Zhong, L | 1 |
Chen, B | 1 |
Caceres, J | 1 |
Atal, P | 1 |
Arora, R | 1 |
Yee, D | 1 |
Padala, SK | 1 |
Lavelle, MP | 1 |
Sidhu, MS | 1 |
Cabral, KP | 1 |
Morrone, D | 1 |
Boden, WE | 5 |
Toth, PP | 1 |
Kim, CH | 1 |
Park, TK | 1 |
Cho, SW | 1 |
Oh, MS | 1 |
Lee, DH | 1 |
Seong, CS | 1 |
Gwag, HB | 1 |
Lim, AY | 1 |
Yang, JH | 1 |
Song, YB | 1 |
Hahn, JY | 1 |
Choi, JH | 1 |
Lee, SH | 1 |
Gwon, HC | 1 |
Ahn, J | 1 |
Carriere, KC | 1 |
Choi, SH | 1 |
Turgeon, RD | 1 |
Pearson, GJ | 1 |
Graham, MM | 1 |
Werner, GS | 1 |
Martin-Yuste, V | 1 |
Hildick-Smith, D | 1 |
Boudou, N | 1 |
Sianos, G | 1 |
Gelev, V | 1 |
Rumoroso, JR | 1 |
Erglis, A | 1 |
Christiansen, EH | 1 |
Escaned, J | 1 |
di Mario, C | 1 |
Hovasse, T | 1 |
Teruel, L | 1 |
Bufe, A | 1 |
Lauer, B | 1 |
Bogaerts, K | 1 |
Goicolea, J | 1 |
Spratt, JC | 1 |
Gershlick, AH | 1 |
Galassi, AR | 1 |
Louvard, Y | 1 |
Kloner, RA | 2 |
Goggin, P | 1 |
Goldstein, I | 1 |
Hackett, G | 1 |
Kirby, MG | 1 |
Osterloh, I | 1 |
Parker, JD | 4 |
Sadovsky, R | 1 |
Ferrari, R | 1 |
Pavasini, R | 1 |
Camici, PG | 1 |
Crea, F | 1 |
Danchin, N | 1 |
Pinto, F | 1 |
Manolis, A | 1 |
Marzilli, M | 1 |
Rosano, GMC | 1 |
Lopez-Sendon, J | 2 |
Fox, K | 2 |
Peri-Okonny, PA | 2 |
Patel, KK | 1 |
Jones, PG | 1 |
Breeding, T | 1 |
Gosch, KL | 1 |
Spertus, JA | 3 |
Arnold, SV | 1 |
Grantham, JA | 1 |
Gosch, K | 1 |
Kirtane, A | 1 |
Sapontis, J | 1 |
Lombardi, W | 1 |
Karmpaliotis, D | 1 |
Moses, J | 1 |
Nicholson, W | 1 |
Salisbury, AC | 1 |
Ahmed, AS | 1 |
Ghati, N | 1 |
Sharma, G | 1 |
Malhi, AS | 1 |
Kang, JS | 1 |
Goodman, SG | 1 |
Yan, RT | 1 |
Pesant, Y | 1 |
Graham, JJ | 1 |
Fitchett, D | 1 |
Wong, GC | 1 |
Rose, BF | 2 |
Spencer, FA | 1 |
Yan, AT | 1 |
Jacobshagen, C | 1 |
Münzel, T | 3 |
Daiber, A | 2 |
Gori, T | 3 |
Yamashina, Y | 1 |
Yagi, T | 1 |
Namekawa, A | 1 |
Ishida, A | 1 |
Mibiki, Y | 1 |
Sato, H | 1 |
Nakagawa, T | 1 |
Sakuramoto, M | 1 |
Sato, E | 1 |
Komatsu, J | 1 |
Thadani, U | 11 |
Beck, DT | 1 |
Martin, JS | 1 |
Casey, DP | 1 |
Avery, JC | 1 |
Sardina, PD | 1 |
Braith, RW | 1 |
Takahashi, J | 1 |
Nihei, T | 1 |
Takagi, Y | 1 |
Miyata, S | 1 |
Odaka, Y | 1 |
Tsunoda, R | 1 |
Seki, A | 1 |
Sumiyoshi, T | 1 |
Matsui, M | 1 |
Goto, T | 1 |
Tanabe, Y | 1 |
Sueda, S | 1 |
Momomura, S | 1 |
Yasuda, S | 1 |
Ogawa, H | 2 |
Shimokawa, H | 1 |
Facchini, E | 1 |
Degiovanni, A | 1 |
Cavallino, C | 1 |
Lupi, A | 1 |
Rognoni, A | 1 |
Bongo, AS | 1 |
Giuseppe, C | 1 |
Paul, J | 1 |
Hans-Ulrich, I | 1 |
Husted, SE | 1 |
Ohman, EM | 1 |
Aronow, WS | 10 |
Xie, W | 1 |
Giannopoulos, AA | 1 |
Giannoglou, GD | 1 |
Chatzizisis, YS | 1 |
Park, T | 1 |
Park, JY | 1 |
Seo, HS | 2 |
Choi, SY | 1 |
Byun, JK | 1 |
Park, SH | 2 |
Park, EJ | 1 |
Choi, JY | 1 |
Lee, JJ | 1 |
Lee, S | 1 |
Na, JO | 2 |
Choi, CU | 2 |
Lim, HE | 1 |
Kim, JW | 2 |
Kim, EJ | 2 |
Park, CG | 2 |
Oh, DJ | 2 |
Glezer, M | 1 |
Riccioni, G | 1 |
Vitulano, N | 1 |
D'Orazio, N | 1 |
Kim, JH | 1 |
Ko, YH | 1 |
Kosmicki, MA | 1 |
Lisi, M | 1 |
Miller, MR | 1 |
Wadsworth, RM | 1 |
Podolec, P | 1 |
Kopeć, G | 1 |
Maron, DJ | 1 |
Mancini, GB | 1 |
Hartigan, PM | 1 |
Sedlis, SP | 1 |
Bates, ER | 1 |
Kostuk, WJ | 1 |
Dada, M | 1 |
Berman, DS | 1 |
Shaw, LJ | 1 |
Chaitman, BR | 1 |
Teo, KK | 1 |
O'Rourke, RA | 3 |
Weintraub, WS | 1 |
Oikawa, Y | 1 |
Matsuno, S | 2 |
Yajima, J | 1 |
Nakamura, M | 1 |
Ono, T | 1 |
Ishiwata, S | 1 |
Fujimoto, Y | 1 |
Aizawa, T | 1 |
Pfister, O | 1 |
Wei, J | 1 |
Wu, T | 1 |
Yang, Q | 1 |
Chen, M | 1 |
Ni, J | 1 |
Huang, D | 1 |
Dvir, D | 1 |
Battler, A | 1 |
Schulz, E | 1 |
Kones, R | 1 |
Hanai, Y | 1 |
Mita, M | 1 |
Hishinuma, S | 1 |
Shoji, M | 1 |
Dagenais, GR | 1 |
Lu, J | 1 |
Faxon, DP | 2 |
Kent, K | 1 |
Lago, RM | 1 |
Lezama, C | 1 |
Hueb, W | 2 |
Weiss, M | 2 |
Slater, J | 1 |
Frye, RL | 1 |
Neumaier, J | 1 |
Deedwania, PC | 3 |
Carbajal, EV | 3 |
Glasser, SP | 1 |
Willard, J | 1 |
Defelice, A | 1 |
Lawrence, J | 1 |
Hung, J | 1 |
Obot, E | 1 |
Girton, J | 1 |
Targum, S | 1 |
Throckmorton, D | 1 |
Mangano, D | 1 |
Lipicky, RJ | 2 |
Custodis, F | 1 |
Laufs, U | 1 |
Horinaka, S | 1 |
Stewart, A | 1 |
Rao, JN | 1 |
Lanza, GA | 1 |
Maseri, A | 3 |
Suresh, V | 1 |
Levy, R | 1 |
Weber, M | 1 |
Hamm, C | 1 |
Lupanov, VP | 2 |
Kazachkina, SS | 1 |
Naumov, VG | 1 |
Hori, T | 1 |
Matsubara, T | 1 |
Ishibashi, T | 1 |
Ozaki, K | 1 |
Tsuchida, K | 1 |
Mezaki, T | 1 |
Tanaka, T | 1 |
Nasuno, A | 1 |
Kubota, K | 1 |
Nakamura, Y | 1 |
Yamazoe, M | 1 |
Aizawa, Y | 1 |
Nishio, M | 1 |
Maitland-van der Zee, AH | 1 |
Klungel, OH | 1 |
Stricker, BH | 1 |
van der Kuip, DA | 1 |
Witteman, JC | 1 |
Hofman, A | 1 |
Leufkens, HG | 1 |
de Boer, A | 1 |
Jain, A | 1 |
Wadehra, V | 1 |
Timmis, AD | 1 |
Dietz, R | 1 |
Rauch, B | 2 |
Hirai, N | 1 |
Kawano, H | 2 |
Yasue, H | 3 |
Shimomura, H | 1 |
Miyamoto, S | 1 |
Soejima, H | 1 |
Kajiwara, I | 1 |
Sakamoto, T | 1 |
Yoshimura, M | 2 |
Nakamura, H | 1 |
Yodoi, J | 1 |
Ono, S | 1 |
Takeishi, Y | 1 |
Yamaguchi, H | 1 |
Abe, S | 1 |
Tachibana, H | 1 |
Sato, T | 1 |
Kubota, I | 1 |
PHILLIPS, E | 1 |
GERSTNER, K | 1 |
WEITZMAN, D | 1 |
FRIEND, DG | 1 |
O'HARE, JP | 1 |
LEVINE, HD | 1 |
BARSOTTI, M | 1 |
DRASSDO, A | 1 |
FULLER, HL | 1 |
KASSEL, LE | 1 |
HELLER, EM | 1 |
DE MESQUITA, GH | 1 |
BRAUN, V | 1 |
DAVID, A | 1 |
ROULEAU, Y | 1 |
TAQUINI, AC | 1 |
BENGOLEA, AM | 1 |
ASLAN, CM | 1 |
SAMUELS, SS | 1 |
SHAFTEL, HE | 1 |
OSIPOVA, ZV | 1 |
CASS, LJ | 1 |
COHEN, JD | 1 |
BALL, GD | 1 |
BILL, CE | 1 |
BISLEY, BL | 1 |
BUSH, JP | 1 |
GOULDER, RV | 1 |
LEVIN, DA | 1 |
MALLETT, CF | 1 |
WHEATLEY, DP | 1 |
JAFFE, GV | 1 |
McGUINNESS, BW | 1 |
BATTERMAN, RC | 1 |
MOURATOFF, GJ | 1 |
BUNN, WH | 1 |
CHREMOS, AN | 1 |
COLE, SL | 1 |
KAYE, H | 2 |
GRIFFITH, GC | 1 |
DZIAK, VN | 1 |
BRACHFELD, N | 1 |
WHITWORTH, CG | 1 |
GRANT, WM | 1 |
BRIQUEMONT, F | 1 |
HINES, MO | 1 |
PUECH, P | 1 |
DATEY, KK | 1 |
DALVI, CP | 1 |
RISEMAN, JE | 1 |
KORETSKY, S | 1 |
ALTMAN, GE | 1 |
KALANOVIC-KANGRGA, R | 1 |
MILENKOVIC-KROTIN, J | 1 |
LEVIN, AI | 1 |
SMOLENSKII, GA | 1 |
OZEROVA, AI | 1 |
TSCHIRDEWAHN, B | 1 |
KLEPZIG, H | 2 |
LOB, M | 1 |
MYHRE, JR | 1 |
NORDQVIST, P | 1 |
VARNAUSKAS, E | 1 |
RUSSEK, HI | 4 |
FUNK, EH | 1 |
Suzuki, N | 1 |
Seto, S | 1 |
Koide, Y | 1 |
Sato, O | 1 |
Hirano, H | 1 |
Yano, K | 1 |
Hutter, AM | 3 |
Emmick, JT | 1 |
Mitchell, MI | 1 |
Denne, J | 1 |
Jackson, G | 3 |
Idrisova, EM | 1 |
Borovkova, NV | 1 |
Kladieva, EA | 1 |
Chernov, VI | 1 |
Demochko, AV | 1 |
Shishkina, AA | 1 |
Vorob'eva, EV | 1 |
Karpov, RS | 1 |
Takagi, S | 1 |
Goto, Y | 1 |
Hirose, E | 1 |
Terashima, M | 1 |
Sakuragi, S | 1 |
Suzuki, S | 1 |
Tsutsumi, Y | 1 |
Miyazaki, S | 1 |
Nonogi, H | 1 |
Shlyakhto, EV | 1 |
Almazov, VV | 1 |
Nifontov, EM | 1 |
Vakhrameyeva, IV | 1 |
Rudomanov, OG | 1 |
Zakharov, DV | 1 |
Kazarin, VV | 1 |
Vakhrameyeva, NV | 1 |
Ekbom, K | 1 |
Sjöstrand, C | 1 |
Svensson, DA | 1 |
Waldenlind, E | 1 |
PALMER, JH | 1 |
RAMSEY, CG | 1 |
Nicholls, C | 1 |
Sani, M | 1 |
Filippi, A | 1 |
Gensini, G | 1 |
Bignanimi, AA | 1 |
Sabatini, A | 1 |
Mazzaglia, G | 1 |
Cricelli, C | 1 |
Horowitz, JD | 3 |
van der Sloot, JA | 1 |
Huikeshoven, M | 1 |
Tukkie, R | 1 |
Verberne, HJ | 1 |
van der Meulen, J | 1 |
van Eck-Smit, BL | 1 |
van Gemert, MJ | 1 |
Tijssen, JG | 2 |
Beek, JF | 1 |
NAEGELE, CF | 1 |
REGAN, FD | 1 |
PFEIFFER, H | 1 |
Rosenkranz, S | 1 |
Erdmann, E | 1 |
Nakajima, D | 1 |
Negoro, N | 1 |
Nakaboh, A | 1 |
Nakakoji, T | 1 |
Hoshiga, M | 1 |
Nariyama, J | 1 |
Ishihara, T | 1 |
Hanafusa, T | 1 |
Abrams, J | 11 |
Martsevich, SIu | 6 |
Bolla, M | 1 |
Almirante, N | 1 |
Benedini, F | 2 |
Crowe, B | 1 |
Abbas, S | 1 |
Meany, B | 1 |
de Haan, J | 1 |
Cahill, MR | 1 |
Aguiar-Souto, P | 1 |
Silva-Melchor, L | 1 |
Ortigosa-Aso, FJ | 1 |
Wang, G | 1 |
Wang, L | 1 |
Xiong, ZY | 1 |
Mao, B | 1 |
Li, TQ | 1 |
Bhatt, AB | 1 |
Stone, PH | 4 |
Rodgers, T | 1 |
Diaz, A | 1 |
Tardif, JC | 1 |
Butler, AR | 1 |
Shilov, AM | 1 |
Ruzyllo, W | 1 |
Tendera, M | 1 |
Ford, I | 1 |
Fox, KM | 1 |
Lopes, NH | 1 |
Gersh, BJ | 1 |
Soares, P | 1 |
Machado, LA | 1 |
Jatene, FB | 1 |
Oliveira, SA | 1 |
Ramires, JA | 1 |
Ndegwa, S | 1 |
Iankovskaia, AV | 1 |
Zinchuk, MA | 1 |
Ninomiya, Y | 1 |
Hamasaki, S | 1 |
Saihara, K | 1 |
Ishida, S | 1 |
Kataoka, T | 1 |
Ogawa, M | 1 |
Orihara, K | 1 |
Oketani, N | 1 |
Fukudome, T | 1 |
Okui, H | 1 |
Ichiki, T | 1 |
Shinsato, T | 1 |
Kubozono, T | 1 |
Mizoguchi, E | 1 |
Ichiki, H | 1 |
Tei, C | 1 |
Casella, F | 1 |
Bossi, I | 1 |
Pisano, G | 1 |
Montano, N | 1 |
Osnes, JB | 1 |
Opie, LH | 4 |
Tancredi, RG | 1 |
Ermilov, LP | 1 |
Kuleshova, EV | 1 |
Treshkur, TV | 1 |
Andreeva, IV | 1 |
Gemelli, A | 2 |
Turi, Z | 1 |
Cohn, PF | 4 |
Firth, BG | 1 |
Hillis, LD | 1 |
Willerson, JT | 1 |
Bache, RJ | 1 |
Masud, AR | 1 |
Bhayana, JN | 1 |
Kübler, W | 4 |
Powles, AC | 1 |
Zilcher, H | 1 |
Glogar, D | 1 |
Zelis, R | 1 |
Reeves, TJ | 1 |
Harlay, A | 1 |
Ng, RA | 1 |
Ferrero, C | 1 |
Ferrero, JD | 1 |
Weser, C | 1 |
Terry, RW | 1 |
Hecht, HS | 1 |
Rahimtoola, SH | 1 |
Segal, BL | 7 |
Kotler, MN | 6 |
Iskandrian, AS | 5 |
Goosby, E | 1 |
Goldschlager, N | 1 |
Ekelund, LG | 1 |
Kelly, DT | 1 |
Crawford, MH | 4 |
Vlay, SC | 2 |
Reid, PR | 1 |
Weissberg, PL | 1 |
Banka, VS | 2 |
Bodenheimer, MM | 2 |
Helfant, RH | 2 |
Busse, R | 1 |
Bassenge, E | 2 |
Van Hamersveld, DD | 1 |
Stewart, JR | 1 |
Phaneuf, DC | 1 |
Bélanger, L | 1 |
Dumont, GR | 1 |
Heinecker, R | 1 |
Kuch, J | 1 |
Reichek, N | 3 |
Conti, RC | 1 |
Hill, JA | 2 |
Feldman, RL | 2 |
Mehta, JL | 2 |
Pepine, CJ | 3 |
Meyer, J | 1 |
Geddes, JS | 1 |
Missri, J | 1 |
Miller, A | 1 |
Burden, LL | 1 |
Atwell, K | 1 |
Hoekenga, D | 1 |
Friedemann, M | 1 |
Bölter, C | 1 |
Heupler, FA | 1 |
Chatterjee, K | 1 |
Rouleau, JL | 1 |
Parmley, WW | 1 |
Taplin, NE | 1 |
Epstein, SE | 3 |
Palmeri, ST | 1 |
Brau, J | 1 |
Bénacerraf, A | 1 |
Lévy, A | 1 |
Veau, P | 1 |
Rakotovao, A | 1 |
Mazur, NA | 2 |
Sidorenko, BA | 2 |
Kulikova, TV | 1 |
Nekrutman, EA | 1 |
Matveeva, LS | 1 |
Harris, PJ | 1 |
Sterz, H | 1 |
Kronik, G | 1 |
Muller, JE | 1 |
Turi, ZG | 1 |
Pearle, DL | 1 |
Schneider, JF | 1 |
Serfas, DH | 1 |
Morrison, J | 1 |
Rude, RE | 1 |
Rosner, B | 1 |
Sobel, BE | 1 |
Demma, FJ | 1 |
Wilson, RR | 1 |
Maclean, D | 1 |
Feely, J | 1 |
Arsura, E | 1 |
Lichstein, E | 1 |
Guadagnino, V | 1 |
Nicchi, V | 1 |
Sanders, M | 1 |
Hollander, G | 1 |
Greengart, A | 1 |
Fung, HL | 3 |
Silber, S | 4 |
Marten, W | 1 |
Haase, W | 1 |
Inou, T | 1 |
Aono, J | 1 |
Akima, M | 1 |
Sakai, K | 1 |
Shakarova, SSh | 1 |
Metelitsa, VI | 9 |
Strel'tsov, AA | 1 |
Vygodin, VA | 3 |
Yamabe, H | 1 |
Kobayashi, K | 1 |
Fukuzaki, H | 1 |
Rietbrock, N | 1 |
Woodcock, BG | 1 |
Severi, S | 1 |
Davies, G | 1 |
Marzullo, P | 1 |
L'Abbate, A | 2 |
Lichtlen, PR | 3 |
Komarov, FI | 1 |
Ol'binskaia, LI | 1 |
Bragina, GI | 1 |
Martynov, AI | 1 |
Belinskaia, TF | 1 |
Freeman, WR | 1 |
Peter, T | 2 |
Mandel, WJ | 1 |
Dipalma, JR | 1 |
Halawa, B | 2 |
Mazurek, W | 1 |
Kuc, K | 1 |
Rudolph, W | 7 |
Blasini, R | 2 |
Kraus, F | 2 |
Glancy, DL | 1 |
McGregor, M | 1 |
Armstrong, PW | 1 |
Moffat, JA | 1 |
Lumholtz, IB | 1 |
Gleichmann, U | 1 |
Ohlmeier, H | 1 |
Trieb, G | 1 |
Mannebach, H | 1 |
Russell, RO | 3 |
Rogers, WJ | 2 |
Mantle, JA | 1 |
Kouchoukos, NT | 2 |
Karp, RB | 1 |
Oberman, A | 1 |
Charles, ED | 1 |
Kronenfeld, JJ | 1 |
Wayne, J | 1 |
Rackley, CE | 2 |
Resnekov, L | 1 |
Wolk, M | 1 |
Rosati, RA | 2 |
Conti, CR | 3 |
Becker, LC | 2 |
Biddle, TL | 1 |
Schroeder, JC | 1 |
Kaplan, EM | 1 |
Gilbert, JP | 1 |
Frommer, PL | 1 |
Mock, MB | 1 |
Levine, SP | 1 |
Lindenfeld, J | 1 |
Ellis, JB | 1 |
Raymond, NM | 1 |
Krentz, LS | 1 |
Giles, TD | 1 |
Iteld, BJ | 1 |
Quiroz, AC | 1 |
Mautner, RK | 1 |
Noack, E | 1 |
Schlup, P | 2 |
Moses, JW | 1 |
Wertheimer, JH | 1 |
Feldman, M | 1 |
Green, LH | 1 |
Seroppian, E | 1 |
Handin, RI | 1 |
Frömmel, H | 2 |
Metcalfe, MJ | 1 |
Jennings, K | 1 |
Held, P | 1 |
Olsson, G | 3 |
Rutherford, JD | 1 |
Schrör, K | 1 |
Gonska, BD | 1 |
Harreuter, A | 1 |
Bertolini, G | 1 |
Cereda, R | 1 |
Donà, G | 1 |
Gromo, G | 1 |
Levi, S | 1 |
Mizrahi, J | 1 |
Sala, A | 1 |
Bogaert, MG | 2 |
Torfgård, KE | 1 |
Ahlner, J | 1 |
Parisi, AF | 2 |
Burtt, DM | 1 |
Kukushkin, SK | 2 |
Kokurina, EV | 6 |
Bochkareva, EV | 4 |
Shetty, K | 1 |
Bauer, JA | 1 |
Backman, C | 1 |
Jacobsson, KA | 1 |
Linderholm, H | 1 |
Osterman, G | 1 |
Zakirova, AN | 1 |
Mingazetdinova, LN | 1 |
Kamilov, FKh | 1 |
Lankin, VZ | 2 |
Lebedev, AV | 1 |
Konovalova, GG | 2 |
Marks, RG | 1 |
Morris, JJ | 1 |
Scheidt, SS | 1 |
Handberg, E | 1 |
Murphy, K | 1 |
Vaughan, C | 1 |
Fennell, WH | 1 |
Mendes, M | 1 |
Atroshchenko, ES | 1 |
Karpova, IS | 1 |
Reynen, K | 1 |
Thuillez, C | 1 |
Feelisch, M | 1 |
Reid, J | 1 |
Clarke, KW | 1 |
Gray, D | 1 |
Hampton, JR | 2 |
Kozyreva, MP | 1 |
Stepin, J | 1 |
Sheiban, I | 1 |
Tonni, S | 1 |
Benussi, P | 1 |
Marini, A | 1 |
Trevi, GP | 1 |
Parker, JO | 9 |
Kertland, H | 1 |
Monmeneu, JV | 1 |
Bodí, V | 1 |
Sanchís, J | 1 |
Chorro, FJ | 1 |
Llopis, R | 1 |
Insa, L | 1 |
López Merino, V | 1 |
Castaigne, A | 1 |
Scherrer-Crosbie, M | 1 |
Chazouillères, AF | 1 |
Carville, C | 1 |
Olson, HG | 1 |
van Wijngaarden, J | 1 |
van Veldhuisen, DJ | 1 |
de Graeff, PA | 1 |
Stejfa, M | 1 |
Schoebel, FC | 1 |
Leschke, M | 1 |
Heintzen, MP | 1 |
Strauer, BE | 2 |
Abshagen, U | 1 |
Dendorfer, A | 1 |
Syrkin, AL | 1 |
Smulevich, AB | 1 |
Drozdov, DV | 1 |
Drobizhev, MIu | 1 |
Pecherskaia, MB | 1 |
Doughty, RN | 1 |
Sharpe, N | 2 |
Bottomley, A | 1 |
Gramling-Babb, P | 1 |
Miller, MJ | 1 |
Reeves, ST | 1 |
Roy, RC | 1 |
Zile, MR | 1 |
Chirkov, YY | 2 |
Chirkova, LP | 2 |
Schächinger, V | 1 |
Zeiher, AM | 1 |
Inobe, Y | 1 |
Kugiyama, K | 1 |
Miyagi, H | 1 |
Ohgushi, M | 1 |
Tomiguchi, S | 1 |
Takahashi, M | 1 |
Biron, CR | 1 |
Asirvatham, S | 1 |
Sebastian, C | 1 |
Khattar, RS | 1 |
Senior, R | 1 |
Sardina, M | 1 |
Boyce, M | 1 |
Lahiri, A | 1 |
Maisch, B | 1 |
Stason, WB | 1 |
Schmid, CH | 1 |
Niedzwiecki, D | 1 |
Whiting, GW | 1 |
Caubet, JF | 1 |
Cory, D | 1 |
Luo, D | 1 |
Ross, SD | 1 |
Chalmers, TC | 1 |
Hasdai, D | 1 |
Lerman, A | 1 |
Grill, DE | 1 |
Rihal, CS | 1 |
Holmes, DR | 1 |
Larrat, EP | 1 |
Heidenreich, PA | 2 |
McDonald, KM | 2 |
Hastie, T | 2 |
Fadel, B | 2 |
Hagan, V | 2 |
Lee, BK | 2 |
Hlatky, MA | 2 |
Holmes, AS | 1 |
Kendall, MJ | 2 |
Toescu, V | 1 |
Nuttall, SL | 1 |
McTaggart, D | 1 |
Barak, N | 1 |
Zemel, R | 1 |
Ben-Ari, Z | 1 |
Braun, M | 1 |
Tur-Kaspa, R | 1 |
Gazewood, JD | 1 |
Darius, H | 1 |
Waller, DG | 1 |
Pocock, SJ | 1 |
Henderson, RA | 1 |
Clayton, T | 1 |
Lyman, GH | 1 |
Chamberlain, DA | 2 |
Szwed, H | 1 |
Pachocki, R | 1 |
Domzal-Bochenska, M | 1 |
Szymczak, K | 1 |
Szydlowski, Z | 1 |
Paradowski, A | 1 |
Gajos, G | 1 |
Kaluza, G | 1 |
Kulon, I | 1 |
Wator-Brzezińska, A | 1 |
Elikowski, W | 1 |
Kuźniak, M | 1 |
Samuels, BA | 1 |
Diamond, GA | 1 |
Mahrer, PR | 1 |
Denton, TA | 1 |
Patel, JC | 1 |
Schwinger, RH | 1 |
Meinhardt, G | 1 |
Sechtem, U | 1 |
Kaufmann, PA | 1 |
Mandinov, L | 1 |
Seiler, C | 1 |
Hess, OM | 2 |
Panesar, NS | 1 |
Pehrsson, SK | 1 |
Ringqvist, I | 1 |
Ekdahl, S | 1 |
Karlson, BW | 1 |
Ulvenstam, G | 2 |
Persson, S | 1 |
Miyamoto, Y | 1 |
Saito, Y | 1 |
Nakayama, M | 1 |
Shimasaki, Y | 1 |
Yoshimura, T | 1 |
Harada, M | 1 |
Kajiyama, N | 1 |
Kishimoto, I | 1 |
Kuwahara, K | 1 |
Hino, J | 1 |
Ogawa, E | 1 |
Hamanaka, I | 1 |
Kamitani, S | 1 |
Takahashi, N | 1 |
Kawakami, R | 1 |
Kangawa, K | 1 |
Nakao, K | 1 |
Khoury, V | 1 |
Kritharides, L | 1 |
Takeyama, J | 1 |
Itoh, H | 1 |
Kato, M | 1 |
Koike, A | 1 |
Aoki, K | 1 |
Fu, LT | 1 |
Watanabe, H | 1 |
Nagayama, M | 1 |
Katagiri, T | 1 |
Kośmicki, M | 1 |
Fihn, SD | 1 |
Williams, SV | 1 |
Daley, J | 1 |
Gibbons, RJ | 1 |
Shilo, L | 1 |
Hadari, R | 1 |
Kovatz, S | 1 |
Qasim, M | 1 |
Shenkman, L | 1 |
Vagueiro, MC | 1 |
Michel, D | 1 |
Klaus, W | 1 |
Julian, DG | 2 |
Asmterdam, EA | 1 |
Mason, DT | 1 |
Arrigo, F | 1 |
Coglitore, S | 1 |
Virga, T | 1 |
Giannetto, M | 1 |
Bramanti, B | 1 |
Melluso, C | 1 |
Consolo, F | 1 |
Strano, A | 1 |
Novo, S | 1 |
Frick, MH | 2 |
Harjola, PT | 1 |
Valle, M | 1 |
Hultgren, HN | 1 |
Pfeifer, JF | 1 |
Angell, WW | 1 |
Lipton, MJ | 1 |
Bilisoly, J | 1 |
Kaverina, NV | 1 |
Chumburidze, VB | 1 |
Warren, SE | 1 |
Francis, GS | 1 |
Plotnick, GD | 1 |
Greene, HL | 1 |
Carliner, NH | 1 |
Fisher, ML | 1 |
Loisance, DY | 1 |
Gronim, SS | 1 |
Likoff, W | 3 |
Segal, B | 1 |
de Feyter, PJ | 1 |
Majid, PA | 1 |
Wardeh, R | 1 |
Roos, JP | 1 |
Luchi, RJ | 2 |
Chahine, RA | 1 |
Raizner, AE | 1 |
Vyden, JK | 1 |
Takano, TT | 1 |
Rose, HB | 1 |
Ogawa, T | 1 |
Goldstein, RE | 3 |
Fletcher, GF | 1 |
Alimurung, B | 1 |
Watt, E | 1 |
Richtsmeier, TE | 1 |
Preston, TA | 1 |
Hochrein, H | 2 |
Weber, KT | 1 |
Janicki, JS | 1 |
Sostman, HD | 1 |
Langou, RA | 1 |
Frithz, G | 1 |
Nordgren, L | 1 |
Bender, HW | 1 |
Fisher, RD | 1 |
Faulkner, SL | 1 |
Friesinger, GC | 1 |
Morton, WE | 1 |
Kupersmith, J | 1 |
Paine, TD | 1 |
Baxley, WA | 1 |
Needleman, P | 2 |
van der Kuy, A | 1 |
van den Bemd, AA | 1 |
Beysens, AJ | 1 |
Mathur, VS | 1 |
Guinn, GA | 1 |
Harper, R | 1 |
Hunt, D | 1 |
Loracher, C | 1 |
Dacian, V | 1 |
Frampton, J | 1 |
Buckley, MM | 1 |
Fitton, A | 1 |
Meluzín, J | 1 |
Zeman, K | 1 |
Stĕtka, F | 1 |
Simek, P | 1 |
Kutishenko, NP | 1 |
Eber, B | 1 |
Schumacher, M | 1 |
Zweiker, R | 1 |
Pokan, R | 1 |
Klein, W | 1 |
Schröder, H | 1 |
Trenkwalder, P | 1 |
Lydtin, H | 1 |
Fleury, J | 1 |
Juhani Knuuti, M | 1 |
Wahl, M | 2 |
Wiklund, I | 2 |
Smith, P | 1 |
Alhainen, L | 1 |
Härkönen, R | 1 |
Puska, P | 1 |
Tzivoni, D | 1 |
Hoberg, E | 1 |
Weber, R | 1 |
Lazar, EJ | 2 |
Lazar, JM | 1 |
Frishman, W | 1 |
Seriakov, VV | 1 |
García-Palmieri, MR | 1 |
Mlczoch, J | 1 |
Motz, W | 1 |
Scheler, S | 1 |
Ellyin, FM | 1 |
Kumar, Y | 1 |
Somberg, JC | 1 |
Bortolotti, M | 2 |
Labriola, E | 2 |
Bacchelli, S | 2 |
Degli Esposti, D | 1 |
Sarti, P | 2 |
Brunelli, F | 2 |
Del Campo, L | 1 |
Barbara, L | 2 |
Kirichenko, LL | 1 |
Masenko, VP | 2 |
Evdokimova, AG | 1 |
Iunusov, MA | 1 |
Maxwell, SR | 1 |
Allgén, J | 2 |
Mertens, HM | 1 |
Kurz, T | 1 |
Dubach, P | 1 |
Ratti, R | 1 |
Campbell, RW | 1 |
Boesgaard, S | 1 |
Aldershvile, J | 1 |
Pedersen, F | 1 |
Pietersen, A | 1 |
Madsen, JK | 1 |
Grande, P | 1 |
Kupnovyts'ka, IH | 1 |
Chuklin, SM | 1 |
Ioseliani, DG | 3 |
Rishko, NV | 1 |
Wilson, A | 1 |
Lahti, T | 1 |
Shub, C | 2 |
Nager, F | 3 |
Schneeweiss, A | 1 |
Reisin, L | 1 |
Bleifeld, W | 2 |
Magarian, GJ | 1 |
Leikam, B | 1 |
Palac, R | 1 |
Korochkin, IM | 1 |
Kapustina, GM | 1 |
Babenko, EV | 1 |
Zhuravleva, NIu | 1 |
Bushe, C | 1 |
Banholzer, C | 1 |
Vetter, W | 1 |
Dirschinger, J | 4 |
Reiniger, G | 4 |
Hall, D | 2 |
Jonsson, UE | 1 |
Scheidt, S | 2 |
Vodop'ianova, RS | 1 |
Costa, R | 1 |
Marino, A | 1 |
Kalinkina, OM | 1 |
Perova, NV | 1 |
Zykova, VP | 1 |
Gratsianskiĭ, NA | 1 |
Mel'kina, OE | 1 |
Sokolova, MA | 1 |
Oganov, RG | 1 |
Bichan, NA | 1 |
Gol'dberg, GA | 1 |
Marzocchi, A | 1 |
Esposti, AD | 1 |
Saito, D | 1 |
Haraoka, S | 1 |
Bayeric, A | 1 |
Scardi, S | 3 |
Pollavini, G | 2 |
Urumbaev, RK | 1 |
Slastnikova, ID | 2 |
Shelest, AN | 1 |
Shapkin, EI | 1 |
Cherevatov, BG | 1 |
Kucherenko, OD | 1 |
Matlakhov, AN | 1 |
Engelmann, L | 1 |
Wetzler, G | 1 |
Kucher, A | 1 |
Volkov, VI | 1 |
Ladnyĭ, AI | 1 |
Penkov, N | 1 |
Sirakova, V | 1 |
Lekkerkerker, JF | 1 |
Weber, S | 1 |
Vetrovec, GW | 1 |
Nesto, R | 1 |
Gerber, FR | 1 |
Hamm, CW | 1 |
Kupper, W | 1 |
Becker, RC | 1 |
Gore, JM | 2 |
Alpert, JS | 2 |
Schoberberger, R | 1 |
Schwarz, B | 1 |
Kunze, M | 1 |
Frishman, WH | 4 |
Brunelli, C | 1 |
Cristofani, R | 1 |
Beyerle, A | 1 |
Sumarokov, AB | 1 |
Hoshio, A | 1 |
Kotake, H | 1 |
Mashiba, H | 1 |
Zaruba, AIu | 2 |
Kutsenko, AI | 2 |
Ma'lginov, SV | 1 |
Chuĭkin, NA | 1 |
Korr, KS | 2 |
Bough, EW | 2 |
Patterson, D | 1 |
Waters, DD | 1 |
Hanger, KH | 1 |
Reichman, MJ | 1 |
Rich, VB | 1 |
Young, PM | 1 |
Shulman, RS | 1 |
Heikkilä, J | 2 |
Vlietstra, RE | 1 |
McGoon, MD | 1 |
Schroeder, JS | 1 |
Beier-Scott, L | 1 |
Ginsburg, R | 1 |
Bristow, MR | 1 |
McAuley, BJ | 1 |
Savenkov, MP | 1 |
Valiakhmetova, ET | 1 |
Savkian, KZ | 1 |
Urbaszek, W | 1 |
Cairns, JA | 1 |
Mshvidobadze, TA | 2 |
Vasilidze, TV | 1 |
Movelidze, TA | 2 |
Khimenko, PL | 1 |
Hugenholtz, P | 1 |
Serruys, P | 1 |
Laird-Meeter, K | 2 |
Fioretti, P | 1 |
Eberts, MA | 1 |
Thieuleux, FA | 1 |
Vilarem, D | 1 |
Lablanche, JM | 1 |
Asseman, PA | 1 |
Thery, C | 1 |
Bertrand, ME | 1 |
Olsson, SB | 1 |
Bigger, JT | 1 |
Gaska, JA | 1 |
Scott, SM | 1 |
Deupree, RH | 1 |
Rapaport, E | 1 |
Rabotnikov, VS | 1 |
Razuvaeva, IA | 1 |
Bingle, JF | 1 |
Mayhew, HE | 1 |
Teicher, M | 2 |
Svendsen, JH | 1 |
Amtorp, O | 1 |
Koster, RW | 1 |
John, RM | 1 |
Swanton, RH | 1 |
Simoons, ML | 1 |
de Feijter, PJ | 1 |
Hugenholtz, PG | 1 |
Lubsen, J | 1 |
Leeman, DE | 1 |
McCabe, CH | 1 |
Lorell, BH | 1 |
Kellett, MA | 1 |
McKay, RG | 1 |
Varricchione, T | 1 |
Baim, DS | 1 |
Cannon, PJ | 1 |
Connell, PA | 1 |
Stockley, IH | 1 |
Garner, ST | 1 |
Fry, J | 1 |
Seth, A | 1 |
Perry, RA | 1 |
Shiu, MF | 1 |
Robinson, D | 1 |
Chan, PK | 1 |
Heo, JY | 1 |
Garibian, G | 1 |
Askenase, A | 1 |
Ware, JH | 1 |
DeWood, MA | 1 |
Eich, RH | 1 |
Pietro, DA | 1 |
Nesto, RW | 1 |
Sharma, SC | 1 |
Chourashy, BK | 1 |
Hütter, P | 1 |
Strein, K | 1 |
Whitsett, T | 1 |
Hamilton, SF | 1 |
Flaherty, JT | 1 |
Cowan, JC | 1 |
Jähnchen, E | 1 |
Schneider, W | 2 |
Kaltenbach, M | 2 |
Nyberg, G | 3 |
Chinoy, DA | 1 |
Stewart, DJ | 1 |
Brest, AN | 1 |
Farrell, B | 1 |
Lahey, KA | 1 |
Nordlander, R | 3 |
Andersson, KE | 1 |
Hoglund, P | 1 |
Pustovoĭt, GD | 1 |
Kukharchuk, VV | 1 |
Karpov, IuA | 2 |
Noeva, EA | 2 |
Fye, WB | 1 |
Smitherman, TC | 1 |
Fujie, S | 1 |
Hirosawa, K | 1 |
Rehnqvist, N | 1 |
Carlens, P | 1 |
Lindström, E | 1 |
Lundman, T | 1 |
Aberg, A | 1 |
Aström, H | 1 |
Stoss, P | 1 |
Erhardt, E | 1 |
Batlouni, M | 1 |
Forth, W | 1 |
Tofler, GH | 1 |
Henderson, R | 1 |
Fromage, P | 1 |
André-Fouet, X | 1 |
Ollagnier, M | 1 |
Kantelip, JP | 1 |
Spector, R | 1 |
Savvateev, KL | 1 |
Corwin, S | 1 |
Reiffel, JA | 1 |
Klütsch, K | 1 |
Grosswendt, J | 1 |
Schöniger, F | 1 |
Koch, E | 1 |
Luomanmäki, K | 1 |
Tattersall, AB | 1 |
Bridgman, KM | 1 |
Carr, M | 1 |
Imhof, PR | 1 |
Shell, WE | 1 |
Lehmann, HU | 1 |
Lesch, M | 1 |
Gorlin, R | 1 |
Gold, HK | 1 |
Leinbach, RC | 1 |
Sanders, CA | 1 |
Buckley, MJ | 1 |
Mundth, ED | 1 |
Austen, WG | 1 |
McNeer, JF | 1 |
Starmer, CF | 1 |
Bartel, AG | 1 |
Behar, VS | 1 |
Kong, Y | 1 |
Peter, RH | 1 |
Fortuin, NJ | 1 |
Judge, TG | 1 |
Charlier, R | 1 |
Stipe, AA | 1 |
Fink, GB | 1 |
Keyriläinen, O | 1 |
Uusitalo, AJ | 1 |
Tempero, KF | 1 |
Messini, M | 1 |
Parratt, JR | 1 |
Siepe, O | 1 |
Cooper, P | 1 |
Dockweiler, J | 1 |
Livesley, B | 1 |
Catley, PF | 1 |
Campbell, RC | 1 |
Oram, S | 1 |
Klaus, AP | 1 |
Zaret, BL | 1 |
Pitt, BL | 1 |
Ross, RS | 1 |
Alberto, S | 1 |
Lavarino, A | 1 |
Phipps, FC | 1 |
Stokinger, HE | 1 |
Krantz, JC | 1 |
Sweatman, T | 1 |
Strauss, G | 1 |
Selzer, A | 1 |
Cohn, KE | 1 |
Lang, S | 1 |
Johnson, EM | 1 |
Winsor, T | 2 |
Mills, B | 1 |
Bakke, OM | 1 |
Rulli, V | 1 |
Nardelli, A | 1 |
Battock, DJ | 2 |
Alvarez, H | 1 |
Chidsey, CA | 2 |
Harrison, DC | 1 |
Cheng, TO | 1 |
Mabuchi, G | 1 |
Fremont, RE | 1 |
Wendkos, MH | 2 |
Johnson, PC | 1 |
Horton, GE | 1 |
Ogawa, K | 1 |
Gudbjarnason, S | 1 |
Kaplan, MA | 3 |
Spesshardt, K | 1 |
Chesluk, HM | 2 |
Goldbarg, AN | 2 |
Moran, JF | 1 |
Butterfield, TK | 2 |
Nemickas, R | 2 |
Bermudez, GA | 2 |
Morgan, JF | 1 |
Semler, HJ | 2 |
Gorman, PA | 1 |
Evans, JM | 1 |
Rosing, DR | 1 |
Redwood, DR | 1 |
Beiser, GD | 1 |
Davies, A | 1 |
Orvis, HH | 1 |
Leslie, RE | 1 |
Gensini, GG | 1 |
Kelly, AE | 1 |
Da Costa, BC | 1 |
Huntington, PP | 1 |
Zdichynec, B | 1 |
Krauss, KR | 1 |
DeSanctis, RW | 1 |
Kimura, E | 1 |
Yoshida, K | 1 |
Ushiyama, K | 1 |
Wolff, K | 1 |
Giusti, C | 1 |
Sepaha, GC | 1 |
Jain, SR | 1 |
Chatterji, AN | 1 |
Chandrakar, MP | 1 |
Raynaud, J | 1 |
Dravet, JL | 1 |
Souteyrand, P | 1 |
Gefter, VA | 1 |
Kokushkin, N | 1 |
Galkina, GA | 1 |
Bidwai, PS | 1 |
Khattri, HN | 1 |
Vohra, RK | 1 |
Berry, JN | 1 |
Feigl, EO | 1 |
Beller, BM | 1 |
Abrahamsen, AM | 1 |
Kiil, F | 1 |
Jacobs, LJ | 1 |
Speckert, H | 1 |
Strasburger, KH | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Outcomes and Safety in Patients Treated With STAR and Deferred Stenting After Unsuccessful CTO PCI[NCT05089864] | 150 participants (Anticipated) | Interventional | 2021-11-23 | Recruiting | |||
Prospective Evaluation of Treatment Strategies in Patients Presenting With Chronic Total Occlusions at Coronary Angiogram[NCT04145167] | 400 participants (Anticipated) | Observational [Patient Registry] | 2019-10-10 | Recruiting | |||
Computed Tomography Coronary Angiography (CTCA) Prior to Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) - a Feasibility Study[NCT05364827] | 20 participants (Anticipated) | Interventional | 2022-06-30 | Recruiting | |||
A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions[NCT01760083] | 450 participants (Actual) | Interventional | 2013-01-31 | Completed | |||
A Pilot Pre-Phase 1 Clinical Trial to Study How Administering Sublingual Nitric Oxide Donor S-nitroso-N-acetylcysteine Affects the Systemic Blood Pressure in Healthy Human Volunteers.[NCT05798481] | Early Phase 1 | 14 participants (Anticipated) | Interventional | 2024-01-01 | Not yet recruiting | ||
Effect of Ranolazine on Activity Level in Patients With Angina After FFR Based Deferred Intervention[NCT03044964] | Phase 4 | 40 participants (Anticipated) | Interventional | 2017-01-10 | Recruiting | ||
Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes[NCT00006305] | Phase 3 | 2,368 participants (Actual) | Interventional | 2000-09-30 | Completed | ||
[NCT00000489] | Phase 3 | 0 participants | Interventional | 1973-06-30 | Completed | ||
Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
(NCT00006305)
Timeframe: five years
Intervention | participants (Number) |
---|---|
Revascularization and Insulin Providing (IP) | 80 |
Revascularization and Insulin Sensitizing (IS) | 75 |
Medical Therapy and Insulin Providing (IP) | 80 |
Medical Therapy and Insulin Sensitizing (IS) | 81 |
(NCT00006305)
Timeframe: five years
Intervention | participants (Number) |
---|---|
Revascularization and Insulin Providing (IP) | 145 |
Revascularization and Insulin Sensitizing (IS) | 121 |
Medical Therapy and Insulin Providing (IP) | 143 |
Medical Therapy and Insulin Sensitizing (IS) | 140 |
194 reviews available for nitrates and Angina Pectoris
Article | Year |
---|---|
Cardioprotective and Antianginal Efficacy of Nicorandil: A Comprehensive Review.
Topics: Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Coronary Vasospasm; Humans; Nicora | 2023 |
A meta-analysis for Kuanxiong Aerosol on the treatment of angina pectoris.
Topics: Angina Pectoris; Drug Combinations; Humans; Nitrates; Oils, Volatile; Plant Extracts; Treatment Outc | 2020 |
Enhanced external counterpulsation: A unique treatment for the "No-Option" refractory angina patient.
Topics: Angina Pectoris; Counterpulsation; Exercise Tolerance; Humans; Nitrates; Prospective Studies; Qualit | 2021 |
Antianginal Therapy for Stable Ischemic Heart Disease: A Contemporary Review.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Drug Therapy, Combina | 2017 |
Pharmacologic Treatment of Patients With Myocardial Ischemia With No Obstructive Coronary Artery Disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Calcium Chan | 2018 |
A New Perspective on the Nitrate-Phosphodiesterase Type 5 Inhibitor Interaction.
Topics: Angina Pectoris; Animals; Blood Pressure; Contraindications, Drug; Drug Interactions; Erectile Dysfu | 2018 |
Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Human | 2019 |
[Late sodium current and calcium overload--pathogenesis and adequate treatment].
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Atrial Fibrillation; Benzazepines; Calci | 2013 |
More answers to the still unresolved question of nitrate tolerance.
Topics: Angina Pectoris; Chronic Disease; Drug Tolerance; Humans; Nitrates; Nitrites; Vasodilation; Vasodila | 2013 |
Challenges with nitrate therapy and nitrate tolerance: prevalence, prevention, and clinical relevance.
Topics: Angina Pectoris; Delayed-Action Preparations; Drug Interactions; Drug Tolerance; Heart Failure; Huma | 2014 |
Beta-Blockers and Nitrates: Pharmacotherapy and Indications.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Humans; Nitrates; Vasodilator Agents | 2015 |
Use of nitrates in ischemic heart disease.
Topics: Angina Pectoris; Coronary Artery Disease; Delayed-Action Preparations; Drug Tolerance; Humans; Myoca | 2015 |
Pharmacological and emerging therapies in the treatment of chronic angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Chron | 2015 |
Current treatment of hypertension in patients with coronary artery disease recommended by different guidelines.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin Receptor Antagonists; Angiotensin-Converti | 2016 |
Pharmacological approaches of refractory angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Coron | 2016 |
Ivabradine: beyond heart rate control.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Calcium Channel Blockers; Cardiovascular | 2009 |
Long-term use of short- and long-acting nitrates in stable angina pectoris.
Topics: Angina Pectoris; Animals; Drug Tolerance; Humans; Nitrates; Nitric Oxide; Nitroglycerin; Pentaerythr | 2009 |
[Organic nitrates: still interesting after all these years].
Topics: Angina Pectoris; Animals; Drug Tolerance; Free Radicals; Heart; Heart Diseases; Heart Failure; Hemod | 2009 |
[Optimal prevention and pharmacotheraphy in stable angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Calcium Chan | 2009 |
[Cardiovascular disease and sexuality].
Topics: Angina Pectoris; Coitus; Contraindications; Drug Interactions; Female; Heart Failure; Humans; Male; | 2010 |
Nitrates for stable angina: a systematic review and meta-analysis of randomized clinical trials.
Topics: Angina Pectoris; Exercise Test; Headache; Humans; Nitrates; Randomized Controlled Trials as Topic | 2011 |
Conventional and novel drug therapeutics to relief myocardial ischemia.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors | 2010 |
[Treatment of coronary heart disease with nitric oxide donors].
Topics: Angina Pectoris; Coronary Disease; Hemodynamics; Humans; Ischemic Preconditioning; Myocardial Revasc | 2010 |
[Mechanisms and clinical significance of nitrate tolerance].
Topics: Aldehyde Dehydrogenase; Angina Pectoris; Animals; Drug Tolerance; Heart Failure; Humans; Nitrates; O | 2010 |
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Female; Health Behavior; Hum | 2010 |
[Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of β-blockers, nitrates and calcium antagonists].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Controlled C | 2010 |
Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors | 2011 |
Is randomization to placebo safe? Risk in placebo-controlled angina trials: angina risk meta-analysis.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Calcium Channel Blocke | 2011 |
[Conservative therapy of patients with stable coronary heart disease].
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Combined Modal | 2012 |
[Vasodilators and nitrates].
Topics: Angina Pectoris; Humans; Nitrates; Vasodilator Agents | 2011 |
[Update on the treatment with nitrates in ischemic cardiopathy].
Topics: Angina Pectoris; Chronic Disease; Drug Tolerance; Humans; Myocardial Ischemia; Nitrates; Vasodilator | 1999 |
Management of stable angina.
Topics: Adrenergic alpha-Antagonists; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin-Convertin | 2003 |
CORONARY VASOMOTOR RESPONSE TO PHARMACOLOGIC AGENTS.
Topics: Angina Pectoris; Catecholamines; Coronary Vessels; Heart; Humans; Nitrates; Nitroglycerin; Vasodilat | 1964 |
Nitrates and their use with older people.
Topics: Aged; Angina Pectoris; Heart Failure; Humans; Nitrates | 2004 |
Clinical practice. Chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Biomarkers; Calcium Channel Blockers; Chest Pain; Chro | 2005 |
[Nitrates. The place in contemporary therapy of ischemic heart disease].
Topics: Angina Pectoris; Contraindications; Delayed-Action Preparations; Humans; Isosorbide Dinitrate; Myoca | 2005 |
Therapeutic potential of nitrate esters of commonly used drugs.
Topics: Angina Pectoris; Animals; Esters; Humans; Nitrates; Nitric Oxide; Nitric Oxide Donors | 2005 |
Compound salvia pellet, a traditional Chinese medicine, for the treatment of chronic stable angina pectoris compared with nitrates: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; China; Cinnamomum camphora; Drugs, Chinese Herbal; | 2006 |
Current strategies for the prevention of angina in patients with stable coronary artery disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Calcium Chan | 2006 |
Side effects of using nitrates to treat angina.
Topics: Angina Pectoris; Coronary Disease; Drug Interactions; Headache; Humans; Isosorbide Dinitrate; Nitrat | 2006 |
Heart rate slowing versus other pharmacological antianginal strategies.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Calcium Channel Blockers; Cardiotonic Ag | 2006 |
[Nitrates in the practice of treatment of cardiovascular diseases].
Topics: Angina Pectoris; Cardiovascular Diseases; Humans; Isosorbide Dinitrate; Nitrates; Vasodilator Agents | 2006 |
Some pharmacological properties of organic nitrates.
Topics: Angina Pectoris; Animals; Arterioles; Coronary Circulation; Coronary Vessels; Cyclic AMP; Cyclic GMP | 1984 |
Medical management of patients with chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Chronic Disease; Clinical Laboratory Techniques | 1980 |
The effect of drugs on the cardiovascular response to exercise.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Antidepressive Agents; Antihyp | 1981 |
[Treatment of angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Co | 1982 |
Unstable angina: a perspective.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon; Coronary Angiography; Coronary V | 1982 |
Therapeutic progress--review V. Treatment of angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Humans; Nitrates | 1982 |
[Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
Topics: Adrenergic beta-Antagonists; Amyl Nitrite; Angina Pectoris; Animals; Blood Circulation; Calcium Chan | 1982 |
The medical therapy of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Humans; Life Style; Nitrates; Smoking Prevention | 1982 |
[Use of calcium antagonists in the therapy of coronary heart disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium; Coronary Disease; Diltiazem; Drug Therapy, Co | 1983 |
Calcium antagonists and beta blockade--a useful combination.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Drug Thera | 1983 |
Drugs and the heart four years on.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Diuret | 1984 |
[Clinical pharmacology and indications for treatment with calcium antagonists].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Cardia | 1984 |
Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: implications regarding therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Animals; Antic | 1984 |
The transdermal administration of nitrates: an overview.
Topics: Administration, Oral; Administration, Topical; Angina Pectoris; Blood Pressure; Coronary Disease; Ex | 1983 |
Pharmacokinetic determinants of nitrate action.
Topics: Angina Pectoris; Humans; In Vitro Techniques; Kinetics; Liver; Nitrates; Nitroglycerin; Vascular Res | 1984 |
Nitrate delivery systems in perspective. A decade of progress.
Topics: Administration, Intranasal; Administration, Oral; Administration, Topical; Angina Pectoris; Heart Fa | 1984 |
Nitrate tolerance and dependence.
Topics: Ambulatory Care; Angina Pectoris; Animals; Cardiovascular Diseases; Dogs; Drug Tolerance; Heart Fail | 1980 |
Nitrate tolerance in angina therapy. How to avoid it.
Topics: Administration, Sublingual; Angina Pectoris; Drug Administration Schedule; Drug Tolerance; Humans; N | 1995 |
[Organic nitrates. I. Mechanism of action and new therapeutic approaches in myocardial ischemia].
Topics: Angina Pectoris; Coronary Circulation; Coronary Disease; Drug Tolerance; Humans; Nitrates; Vasodilat | 1995 |
[Organic nitrates. II. Dosage and clinical indications].
Topics: Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; H | 1995 |
Short and long-acting oral nitrates for stable angina pectoris.
Topics: Administration, Oral; Angina Pectoris; Delayed-Action Preparations; Drug Therapy, Combination; Drug | 1994 |
Clinical pharmacokinetics of nitrates.
Topics: Angina Pectoris; Delayed-Action Preparations; Drug Administration Routes; Half-Life; Humans; Isosorb | 1994 |
Mechanisms of action of nitrates.
Topics: Angina Pectoris; Blood Platelets; Cyclic GMP-Dependent Protein Kinases; Cytochrome P-450 Enzyme Syst | 1994 |
Revascularization procedures in the treatment of single-vessel coronary disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Calc | 1993 |
Prescribing for angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Humans; Myocardial | 1994 |
Mechanisms of nitrate tolerance.
Topics: Angina Pectoris; Animals; Drug Administration Routes; Drug Therapy, Combination; Drug Tolerance; Hea | 1994 |
Concomitant use of nitrates, calcium channel blockers, and beta blockers for optimal antianginal therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; H | 1994 |
Nitrate therapy and the development of tolerance.
Topics: Angina Pectoris; Drug Tolerance; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Pentaerythri | 1993 |
[Nitrates].
Topics: Angina Pectoris; Coronary Artery Disease; Drug Tolerance; Heart Failure; Humans; Myocardial Infarcti | 1993 |
[Nitrogen monoxide (NO)--the active principle of organic nitrates].
Topics: Angina Pectoris; Animals; Biotransformation; Coronary Disease; Endothelium, Vascular; Humans; Muscle | 1993 |
Organic nitrate therapy for angina pectoris.
Topics: Angina Pectoris; Drug Tolerance; Humans; Nitrates; Vasodilator Agents | 1994 |
[The problem of tolerance to nitrates and the means to resolve it in patients with exertional stenocardia].
Topics: Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Drug Tolerance; Humans; Nitr | 1993 |
Nitrates and angina pectoris.
Topics: Angina Pectoris; Drug Administration Schedule; Drug Tolerance; Humans; Nitrates; Vasodilator Agents | 1993 |
Nitrate tolerance--mechanisms and prevention.
Topics: Angina Pectoris; Drug Administration Schedule; Drug Tolerance; Hemodynamics; Humans; Nitrates | 1993 |
[Apical hypertrophic myocardiopathy and multiple fistulae between the coronary vessels and the left ventricle].
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Coronary Disease; Dru | 1995 |
Medical management of stable angina and unstable angina in the elderly with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Card | 1996 |
[Treatment of Angina pectoris using nitrates].
Topics: Angina Pectoris; Drug Tolerance; Headache; Hemodynamics; Humans; Nitrates | 1996 |
[Conservative treatment concepts for stable angina pectoris in coronary heart disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Coronary Circulation; Corona | 1996 |
[Characteristics of angina pectoris therapy with nitrates].
Topics: Angina Pectoris; Coronary Circulation; Coronary Disease; Dose-Response Relationship, Drug; Drug Admi | 1996 |
[Controlled clinical studies of tolerance development and dosing problems in nitrate therapy].
Topics: Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Admin | 1996 |
[Pharmacology of nitrates and other NO donors].
Topics: Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Hemodynamics; Humans; Muscle, S | 1996 |
Optimal treatment of angina in older patients.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angina Pectoris; Angioplasty, Balloon, Laser-Assiste | 1996 |
Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure.
Topics: Angina Pectoris; Angina, Unstable; Heart Failure; Humans; Nitrates; Vasodilator Agents | 1997 |
Oral nitrates: more than symptomatic therapy in coronary artery disease?
Topics: Administration, Oral; Angina Pectoris; Coronary Disease; Drug Therapy, Combination; Heart Failure; H | 1997 |
[Nitric oxide in therapy of angina pectoris: nitrates or molsidomine?].
Topics: Angina Pectoris; Animals; Coronary Circulation; Drug Tolerance; Humans; Molsidomine; Nitrates; Nitri | 1997 |
Nitrate therapy for stable angina pectoris.
Topics: Angina Pectoris; Drug Therapy, Combination; Drug Tolerance; Humans; Isosorbide Dinitrate; Nitrates; | 1998 |
Choosing the most appropriate treatment for stable angina. Safety considerations.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspiri | 1998 |
Clinical outcome studies of anti-anginal drug therapy for patients with stable coronary disease: an indication for clinical trials.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Co | 1998 |
Safety of nifedipine in angina pectoris: a meta-analysis.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Delayed-Action Preparations; | 1999 |
Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Hu | 1999 |
Angina and its treatment.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antioxidants; Calcium Channel Blockers; Coronary Disea | 1999 |
Cardiology 7. Stable angina pectoris: treatment and referral options.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anti-Inflammator | 1999 |
Role of nitrates for the therapy of coronary artery disease patients in the years beyond 2000.
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Drug Tolerance; Forecasting; Humans; My | 1999 |
Optimal nitrate therapy with a once-daily sustained-release formulation of isosorbide mononitrate.
Topics: Angina Pectoris; Circadian Rhythm; Clinical Trials as Topic; Delayed-Action Preparations; Drug Toler | 1999 |
Use of nitrate in angina.
Topics: Angina Pectoris; Drug Administration Routes; Humans; Nitrates; Nitroglycerin; Treatment Outcome; Vas | 1999 |
Impact of exercise-induced coronary vasomotion on anti-ischemic therapy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers | 2000 |
Optimal medical management of patients with chronic ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel Blocke | 2001 |
[Is it worthwhile to treat stable angina pectoris with long-acting nitrates?].
Topics: Angina Pectoris; Chronic Disease; Coronary Disease; Drug Administration Schedule; Humans; Isosorbide | 2000 |
Combination therapy in angina: a review of combined haemodynamic treatment and the role for combined haemodynamic and cardiac metabolic agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Dr | 2001 |
An evaluation of beta-blockers, calcium antagonists, nitrates, and alternative therapies for stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Complementary Therapies; Evi | 1999 |
[Angina pectoris. Results of investigations to date (author's transl)].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Humans; Nitrates | 1976 |
[Therapy of angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium; Cardiac Glycosides; Heart; Humans; Nitrates; | 1977 |
[Calcium antagonists in cardiology].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Calcium; Coronary Disease; Human | 1978 |
Antianginal drugs.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anabolic Agents; Angina Pectoris; Animals; An | 1979 |
Nitroglycerin and nitrate esters.
Topics: Angina Pectoris; Animals; Blood Pressure; Cardiac Output; Coronary Circulation; Esters; Heart Failur | 1978 |
Clinical use of nitrates. I. Nitrates as antianginal drugs.
Topics: Angina Pectoris; Coronary Circulation; Hemodynamics; Humans; Nitrates; Nitroglycerin | 1979 |
Coronary artery spasm.
Topics: Angina Pectoris; Angina Pectoris, Variant; Constriction, Pathologic; Coronary Angiography; Coronary | 1979 |
Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
Topics: Angina Pectoris; Animals; Biological Availability; Drug Interactions; Drug Tolerance; Hemodynamics; | 1992 |
[The nitrate withdrawal syndrome. A review of the literature and the data from the authors' own research].
Topics: Angina Pectoris; Electrocardiography; Exercise Test; Humans; Nitrates; Nitroglycerin; Physical Exert | 1992 |
[Nisoldipine in comparison with long-term nitrates].
Topics: Angina Pectoris; Animals; Coronary Circulation; Coronary Disease; Coronary Vasospasm; Humans; Myocar | 1992 |
[Organic nitrates. New knowledge about the mechanism of action of an old class of substances].
Topics: Angina Pectoris; Coronary Circulation; Coronary Disease; Cyclic GMP; Cytochrome P-450 Enzyme System; | 1992 |
Long-term management of the patient with stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; H | 1992 |
[Therapeutic possibilities, respective implications in silent ischemia].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Coronary Artery Byp | 1992 |
Angina pectoris and silent ischemia in the elderly: a management update.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Protocols; Co | 1992 |
[Therapy of silent ischemia].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel Blocke | 1992 |
[Drugs acting on the heart in therapy of silent myocardial ischemia].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Coron | 1992 |
Hypothyroidism complicated by angina pectoris: therapeutic approaches.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Calcium Chan | 1992 |
[Recent progress regarding nitrates and their use in stable and unstable angina pectoris, pre-infarction syndrome and myocardial infarct].
Topics: Angina Pectoris; Angina, Unstable; Coronary Circulation; Drug Tolerance; Humans; Myocardial Infarcti | 1992 |
Optimizing antianginal therapy: consensus guidelines.
Topics: Angina Pectoris; Drug Tolerance; Humans; Nitrates | 1992 |
An update on nitrate tolerance: can it be avoided?
Topics: Administration, Cutaneous; Administration, Oral; Angina Pectoris; Drug Tolerance; Humans; Nitrates; | 1992 |
Use of nitrates in ischemic heart disease.
Topics: Angina Pectoris; Coronary Circulation; Coronary Disease; Drug Administration Routes; Hemodynamics; H | 1992 |
Role of nitrates in angina pectoris.
Topics: Angina Pectoris; Drug Tolerance; Humans; Nitrates | 1992 |
Prophylactic nitrate therapy in angina pectoris--is there an optimal treatment regimen?
Topics: Angina Pectoris; Biological Availability; Delayed-Action Preparations; Drug Tolerance; Half-Life; Hu | 1992 |
Medical therapy of stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Humans; Nitrates | 1991 |
[Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Drug Thera | 1991 |
[A combination of antianginal agents in patients with angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; H | 1991 |
The deficiencies of current medical therapy for the management of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Drug Administration Schedule | 1991 |
Nitrate tolerance--can it be prevented?
Topics: Angina Pectoris; Delayed-Action Preparations; Drug Tolerance; Humans; Isosorbide Dinitrate; Nitrates | 1991 |
Is there an optimal prophylactic nitrate therapy?
Topics: Angina Pectoris; Chemistry, Pharmaceutical; Drug Tolerance; Humans; Nitrates | 1991 |
Nitrate therapy: is there an optimal substance and formulation?
Topics: Angina Pectoris; Chemistry, Pharmaceutical; Consumer Behavior; Delayed-Action Preparations; Humans; | 1991 |
Stable angina pectoris: 3. Medical treatment.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Cardi | 1990 |
[Therapy of angina pectoris--state of the art].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Drug | 1990 |
Individualized antianginal therapy guided by systemic arterial pressure.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Antihyperten | 1990 |
Unstable angina: pathophysiology and drug therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Anticoagulants; Aspirin; Calcium Cha | 1990 |
Nitrate therapy in patients with coronary artery disease--preparations and doses with and without development of tolerance.
Topics: Administration, Cutaneous; Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Drug | 1990 |
Nitrate tolerance. A problem during continuous nitrate administration.
Topics: Angina Pectoris; Drug Administration Schedule; Drug Tolerance; Exercise; Humans; Isosorbide Dinitrat | 1990 |
Development of long-acting nitrate delivery systems.
Topics: Administration, Cutaneous; Administration, Oral; Angina Pectoris; Delayed-Action Preparations; Human | 1990 |
Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.
Topics: Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Drug Administration Schedule; Drug T | 1990 |
Angina: evolution of the role of nitrates.
Topics: Angina Pectoris; Exercise Test; Humans; Nitrates; Nitroglycerin; Randomized Controlled Trials as Top | 1990 |
[Current status of pharmacology and therapeutic use of nitro derivatives].
Topics: Angina Pectoris; Angina Pectoris, Variant; Angina, Unstable; Drug Tolerance; Heart Failure; Humans; | 1990 |
Nitrate tolerance in angina pectoris.
Topics: Angina Pectoris; Animals; Drug Tolerance; Female; Humans; Male; Nitrates | 1989 |
Intermittent nitrate therapy in angina pectoris.
Topics: Angina Pectoris; Drug Administration Schedule; Drug Tolerance; Methods; Nitrates; Nitroglycerin | 1989 |
[Is it possible to prevent the phenomenon of tolerance in patients with angina pectoris treated with nitrates?].
Topics: Angina Pectoris; Clinical Protocols; Double-Blind Method; Drug Tolerance; Humans; Male; Nitrates; Ni | 1989 |
[The mechanism of action of nitrates, 1988 status].
Topics: Angina Pectoris; Animals; Coronary Disease; Endothelium, Vascular; Hemodynamics; Humans; Muscle, Smo | 1989 |
[Transdermal forms of nitrates].
Topics: Administration, Cutaneous; Angina Pectoris; Delayed-Action Preparations; Drug Tolerance; Humans; Iso | 1989 |
[Drug therapy of unstable angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Anticoagulants; Calcium Channel Bloc | 1989 |
Postinfarction unstable angina. Pathophysiologic basis for current treatment modalities.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Assisted Circu | 1989 |
[Combination of anti-angina drugs].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Drug Thera | 1989 |
Profile of an ideal antianginal agent.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Coronary Circulation; Humans | 1989 |
Pharmacology of acute effort angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Calcium Channel Blockers; Coronary Circulatio | 1989 |
[Long-term therapy with nitrates. How can continuous effectiveness be achieved?].
Topics: Administration, Cutaneous; Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Drug Admi | 1989 |
[Tolerance of nitrates in the treatment of stenocardia].
Topics: Angina Pectoris; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Nitrates; Physic | 1989 |
Rationale for treating angina pectoris in patients with heart failure.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; H | 1985 |
Selection of optimal drug therapy for the patient with angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel | 1985 |
Calcium antagonists.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium; Calcium Channel Blockers; Coronary Circulatio | 1985 |
Unstable angina: 1985 update.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Anticoagulants | 1986 |
The role of triple therapy in patients with chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Drug Evalua | 1987 |
Antianginal drug therapy for silent myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Humans; Ni | 1987 |
Ischemic heart disease: a patient-specific therapeutic approach with emphasis on quality of life considerations.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon; Calcium Channel Blockers; Corona | 1987 |
Choice of therapy in angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Calcium Channe | 1987 |
The medical treatment of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Humans; Nitrates | 1987 |
[Drug therapy of stable angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Coronary Circulation; Corona | 1987 |
Nifedipine and metoprolol in suspected unstable angina. Unstable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Clinical T | 1987 |
Management of unstable angina soon after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Anticoagulants | 1988 |
The role of nitrates, beta blockers, and calcium antagonists in stable angina pectoris.
Topics: Adrenergic beta-Agonists; Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; Drug | 1988 |
[Nitrate therapy--a causal therapy of the angina pectoris syndrome? New knowledge on the endothelium-derived relaxing factor].
Topics: Angina Pectoris; Biological Factors; Humans; Nitrates; Nitric Oxide; Vasodilator Agents | 1988 |
Nitrate therapy for myocardial ischemic syndrome: current perspectives including tolerance.
Topics: Angina Pectoris; Coronary Circulation; Coronary Disease; Drug Tolerance; Hemodynamics; Humans; Nitra | 1988 |
Nitrate tolerance.
Topics: Angina Pectoris; Drug Tolerance; Hemodynamics; Humans; Male; Nitrates; Nitroglycerin; Time Factors | 1986 |
Relationship between pharmacokinetics and pharmacodynamics of organic nitrates.
Topics: Angina Pectoris; Dose-Response Relationship, Drug; Drug Tolerance; Hemodynamics; Humans; Isosorbide | 1986 |
Treatment of acute anginal attacks with nitrates.
Topics: Administration, Oral; Angina Pectoris; Humans; Nitrates; Nitroglycerin | 1987 |
Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration.
Topics: Angina Pectoris; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitrates; Nitro | 1987 |
Interdependence of pharmacologically-induced and endothelium-mediated coronary vasodilation in antianginal therapy.
Topics: Angina Pectoris; Coronary Circulation; Coronary Vessels; Endothelium, Vascular; Humans; Nitrates; Va | 1988 |
Antianginal drug therapy for silent myocardial ischemia.
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Humans; Nitrates; Sympatholytics | 1988 |
Nitrate therapy in stable angina pectoris.
Topics: Angina Pectoris; Humans; Nitrates | 1987 |
Use of nitrates in the treatment of unstable and variant angina.
Topics: Angina Pectoris; Angina Pectoris, Variant; Angina, Unstable; Humans; Nitrates | 1987 |
Combination of nitrates with other antianginal drugs.
Topics: Angina Pectoris; Drug Therapy, Combination; Humans; Nitrates | 1987 |
Nitrate tolerance in angina pectoris.
Topics: Angina Pectoris; Humans; Nitrates | 1986 |
[Avoidance of tolerance development to long term therapy with nitrates through correct dosage].
Topics: Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administration Schedule | 1986 |
Unstable angina pectoris: the first half century: natural history, pathophysiology, and treatment.
Topics: Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Humans; Nitrates | 1986 |
Nitrate therapy in angina and congestive heart failure.
Topics: Angina Pectoris; Coronary Circulation; Heart Failure; Hemodynamics; Humans; Nitrates | 1985 |
A review of nitrate therapy in stable angina, variant angina, unstable angina and myocardial infarction.
Topics: Angina Pectoris; Angina Pectoris, Variant; Humans; Myocardial Infarction; Nitrates; Physical Exertio | 1985 |
Nitrate therapy for angina pectoris. Current concepts about mechanism of action and evaluation of currently available preparations.
Topics: Administration, Oral; Administration, Topical; Angina Pectoris; Angina, Unstable; Animals; Coronary | 1985 |
Efficacy of different forms of nitrates in angina pectoris.
Topics: Administration, Oral; Angina Pectoris; Calcium; Drug Tolerance; Humans; Isosorbide Dinitrate; Kineti | 1985 |
Pharmacology of nitroglycerin and long-acting nitrates.
Topics: Absorption; Administration, Oral; Administration, Topical; Angina Pectoris; Animals; Cheek; Delayed- | 1985 |
Pharmacological therapy of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arteriosclerosis; Coronary Circulation; Coronary Disea | 1973 |
Vasodilators..
Topics: Adrenergic alpha-Antagonists; Aminophylline; Angina Pectoris; Bradycardia; Bronchial Diseases; Cereb | 1974 |
[Physiopathology of angina and long term antianginal medication. Current concepts].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Blood Flow Velocity; Cardiac Output; Coron | 1974 |
Editorial: Nitrates in the prophylactic treatment of angina pectoris.
Topics: Angina Pectoris; Exercise Test; Heart; Hemodynamics; Humans; Isosorbide Dinitrate; Nitrates; Nitrogl | 1973 |
Angina pectoris: diagnosis, evaluation and therapy.
Topics: Angina Pectoris; Angiography; Digitalis Glycosides; Ethanol; Female; Heart Function Tests; Humans; M | 1973 |
Management of stable angina.
Topics: Administration, Oral; Angina Pectoris; Animals; Coronary Circulation; Delayed-Action Preparations; D | 1973 |
Pharmacological aspects of the coronary circulation.
Topics: Adenine Nucleotides; Angina Pectoris; Angiotensin II; Animals; Atrial Function; Blood Pressure; Coro | 1969 |
Organic nitrates in angina pectoris.
Topics: Administration, Oral; Amyl Nitrite; Angina Pectoris; Blood Pressure; Coronary Circulation; Drug Tole | 1972 |
101 trials available for nitrates and Angina Pectoris
Article | Year |
---|---|
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Chroni | 2018 |
Enhanced external counterpulsation improves endothelial function and exercise capacity in patients with ischaemic left ventricular dysfunction.
Topics: Aged; Angina Pectoris; Brachial Artery; Coronary Artery Disease; Counterpulsation; Epoprostenol; Exe | 2014 |
Coronary endothelial dysfunction associated with a depressive mood in patients with atypical angina but angiographically normal coronary artery.
Topics: Acetylcholine; Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Vessels; Depression; End | 2010 |
Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Calcium Chan | 2009 |
Effects of treatment with once-daily nifedipine CR and twice-daily benidipine on prevention of symptomatic attacks in patients with coronary spastic angina pectoris-Adalat Trial vs Coniel in Tokyo against Coronary Spastic Angina (ATTACK CSA).
Topics: Acetylcholine; Angina Pectoris; Blood Pressure; Coronary Vasospasm; Dihydropyridines; Electrocardiog | 2010 |
Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel | 2011 |
Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel | 2011 |
Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel | 2011 |
Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel | 2011 |
Attenuation of nitrate tolerance and oxidative stress by an angiotensin II receptor blocker in patients with coronary spastic angina.
Topics: Administration, Cutaneous; Aged; Angina Pectoris; Angiotensin Receptor Antagonists; Benzimidazoles; | 2003 |
Enhanced regional washout of technetium-99m-sestamibi in patients with coronary spastic angina.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Calcium Channel Blockers; Coronary Vasospasm; Ergon | 2003 |
Time course of the interaction between tadalafil and nitrates.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Carbolines; Contraindications; Cross-Over Studies; | 2003 |
[Nitrates in therapy of effort angina in hypotensive patients].
Topics: Angina Pectoris; Cross-Over Studies; Exercise Test; Humans; Hypotension; Isosorbide Dinitrate; Male; | 2003 |
Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Chronic Disease; Drug Therapy, Combinatio | 2002 |
Transmyocardial revascularization using an XeCl excimer laser: results of a randomized trial.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Echocardiography; Electrocar | 2004 |
Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Topics: Aged; Amlodipine; Angina Pectoris; Benzazepines; Blood Pressure; Calcium Channel Blockers; Cardioton | 2007 |
Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin-Conv | 2007 |
Comparison of effect between nitrates and calcium channel antagonist on vascular function in patients with normal or mildly diseased coronary arteries.
Topics: Acetylcholine; Aged; Angina Pectoris; Calcium Channel Blockers; Coronary Angiography; Coronary Arter | 2008 |
Drugs and the heart. VII. Which drug for which disease?
Topics: Acute Disease; Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Antihypertensiv | 1980 |
Calcium-blocker therapy for unstable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Co | 1982 |
Role of nitroglycerin in effort angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Dose-Response Relationship, | 1983 |
Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Clinical Trials as Topic; Coronary Artery Bypass; Coro | 1983 |
Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: implications regarding therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Animals; Antic | 1984 |
Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison.
Topics: Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Ma | 1984 |
[Nitrate tolerance: pro and con].
Topics: Angina Pectoris; Cardiac Output; Clinical Trials as Topic; Drug Administration Schedule; Drug Tolera | 1984 |
The prolonged effect of pentaerythritol tetranitrate on exercise capacity in stable effort angina pectoris.
Topics: Administration, Oral; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Double-Blind Method | 1981 |
Unstable angina pectoris: management based on available information.
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Humans; Nitrate | 1982 |
A cross-over study comparing the efficacy of a combination of atenolol and nifedipine at different doses in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angina Pectoris; Atenolol; Cross-Ove | 1995 |
Short and long-acting oral nitrates for stable angina pectoris.
Topics: Administration, Oral; Angina Pectoris; Delayed-Action Preparations; Drug Therapy, Combination; Drug | 1994 |
Effects of digitalis, anti-anginal drugs and arterial hypertension on the relationships between exercise ECG and angiocardiographic variables and on the diagnostic accuracy of exercise ECG in patients with coronary heart disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiocardiography; Calcium Channel Blockers; Coronary | 1994 |
[The antioxidant ceruloplasmin: its effect on lipid peroxidation, blood rheology and the course of stenocardia].
Topics: Adult; Angina Pectoris; Angina, Unstable; Antioxidants; Blood Viscosity; Ceruloplasmin; Delayed-Acti | 1994 |
Characteristics of a contemporary population with angina pectoris. TIDES Investigators.
Topics: Administration, Cutaneous; Aged; Angina Pectoris; Cardiovascular Agents; Cardiovascular Diseases; Co | 1994 |
Left ventricular dysfunction following transient ischaemia induced by transluminal coronary angioplasty. Beneficial effects of calcium antagonists against post-ischaemic myocardial stunning.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Circulation; Coronary Disease | 1993 |
Safety, tolerability, and antiischaemic efficacy of ITF-296, a nitric oxide donor, in patients with chronic stable angina.
Topics: Aged; Angina Pectoris; Benzoxazines; Double-Blind Method; Exercise Test; Hemodynamics; Humans; Injec | 1998 |
Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina.
Topics: Activities of Daily Living; Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Angioplasty, | 2000 |
[Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Calcium; Drug Evaluation; Drug Therapy, C | 2000 |
Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; | 2000 |
Effects of physical training on the recovery of the autonomic nervous activity during exercise after coronary artery bypass grafting: effects of physical training after CABG.
Topics: Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Autonomic Nervous System; Calcium C | 2000 |
Persistence of improved exercise tolerance and degree of revascularization after coronary bypass surgery. A prospective randomized study.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Coronary Artery Bypass; Electrocardiography; Exercise | 1979 |
Unstable angina pectoris: National Cooperative Study Group to Compare Surgical and Medical Therapy.
Topics: Angina Pectoris; Coronary Artery Bypass; Coronary Circulation; Electrocardiography; Employment; Fema | 1978 |
Is the use of long acting nitrates beneficial in the patient with angina pectoris? (The positive side).
Topics: Administration, Oral; Angina Pectoris; Biological Availability; Blood Pressure; Cardiac Output; Clin | 1977 |
Is the use of long acting nitrates beneficial in the patient with angina pectoris? (The negative side).
Topics: Angina Pectoris; Animals; Clinical Trials as Topic; Coronary Circulation; Delayed-Action Preparation | 1977 |
Acute drug testing with nitrates: angina relief during treadmill exercise.
Topics: Adult; Angina Pectoris; Drug Evaluation; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitrates; | 1977 |
Pindolol and alprenolol in angina pectoris: a comparative clinical study.
Topics: Administration, Oral; Adult; Aged; Alprenolol; Angina Pectoris; Clinical Trials as Topic; Exercise T | 1975 |
Prospective randomized study of coronary bypass surgery in stable angina. The first 100 patients.
Topics: Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Evaluation Studies as Topic; Exercise Tes | 1975 |
Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
Topics: Angina Pectoris; Animals; Biological Availability; Drug Interactions; Drug Tolerance; Hemodynamics; | 1992 |
Effects of nifedipine and diltiazem on myocardial ischemia in patients with severe stable angina pectoris treated with nitrates and beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Diltiazem; Double-Blind Method; Electroca | 1992 |
Acute and long-term effects on myocardial ischemia of intermittent and continuous transdermal nitrate therapy in stable angina.
Topics: Administration, Cutaneous; Administration, Oral; Administration, Sublingual; Adrenergic beta-Antagon | 1992 |
[Effects of prolonged-action nitrates on platelet aggregation and prostaglandin formation].
Topics: Angina Pectoris; Delayed-Action Preparations; Humans; Middle Aged; Nitrates; Nitroglycerin; Platelet | 1992 |
Continuous oral N-acetylcysteine treatment and development of nitrate tolerance in patients with stable angina pectoris.
Topics: Acetylcysteine; Administration, Oral; Aged; Angina Pectoris; Double-Blind Method; Drug Tolerance; Ex | 1991 |
A summary index for the assessment of quality of life in angina pectoris.
Topics: Abstracting and Indexing; Administration, Cutaneous; Angina Pectoris; Humans; Male; Middle Aged; Nit | 1991 |
Angina: evolution of the role of nitrates.
Topics: Angina Pectoris; Exercise Test; Humans; Nitrates; Nitroglycerin; Randomized Controlled Trials as Top | 1990 |
[An assessment of the efficacy of a course of using different forms of prolonged-action nitrates in patients with stable stenocardia with the help of repeated daily ECG monitoring].
Topics: Adult; Angina Pectoris; Circadian Rhythm; Coronary Angiography; Delayed-Action Preparations; Drug Ev | 1990 |
[Development and status of nitrate therapy in East Germany].
Topics: Angina Pectoris; Delayed-Action Preparations; Dose-Response Relationship, Drug; Germany, East; Heart | 1989 |
The Nifedipine-Total Ischemia Awareness Program: a national survey of painful and painless myocardial ischemia including results of antiischemic therapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Coronary Disease; Cros | 1989 |
Long-term survival in medically treated patients with ischaemic heart disease and prognostic importance of clinical and electrocardiographic data (the Italian CNR Multicentre Prospective Study OD1).
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Coronary Angiography; Coronary Disease; Cross-Sect | 1989 |
Angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Calcium Channe | 1985 |
Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Benzazepines; Clinical Trials as Topic; C | 1985 |
Metoprolol in acute myocardial infarction. Narcotic analgesics and other antianginal drugs. The MIAMI Trial Research Group.
Topics: Analgesics, Opioid; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Clinical Trials as To | 1985 |
Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angiography; Aspirin; Clinical Trial | 1987 |
Mononitrates in combination with beta-blocker therapy in the treatment of severe angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Delayed-Action | 1987 |
Nifedipine and metoprolol in suspected unstable angina. Unstable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Clinical T | 1987 |
The efficacy of the addition of nifedipine in patients with mixed angina compared to patients with classic exertional angina: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Double-Blind Method; Drug Therapy, Combination; Electr | 1988 |
[Dose-response relationship of nitrate therapy of angina pectoris].
Topics: Administration, Cutaneous; Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; D | 1986 |
[Monotherapy of patients with stenocardia with individually administered doses of delayed-action nitrates (Working Group for Cooperative Studies on Anti-anginal Drugs)].
Topics: Administration, Buccal; Administration, Cutaneous; Administration, Oral; Adult; Aged; Angina Pectori | 1988 |
Nitrate tolerance: the lack of effect of N-acetylcysteine.
Topics: Acetylcysteine; Administration, Oral; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method | 1987 |
[Continuing anti-anginal effectiveness during chronic nitrate therapy in spite of the cessation of hemodynamic partial effects].
Topics: Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Hemodynamics; H | 1986 |
[Avoidance of tolerance development to long term therapy with nitrates through correct dosage].
Topics: Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administration Schedule | 1986 |
Effectiveness of molsidomine in the long-term treatment of exertional angina pectoris and chronic congestive heart failure.
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Electrocard | 1985 |
Tolerance: implications for nitrate use in angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Drug Tolerance; Humans; Nitrates | 1985 |
[Methodological aspects of using the exercise test during clinico-pharmacological trials of anti-angina preparations].
Topics: Adaptation, Physiological; Adult; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topi | 1985 |
Tolerance to the hemodynamic and antianginal effects of the organic nitrates.
Topics: Administration, Oral; Administration, Topical; Angina Pectoris; Dose-Response Relationship, Drug; Do | 1985 |
Prophylactic therapy of angina pectoris with organic nitrates: relationship of drug efficacy and clinical experimental design.
Topics: Angina Pectoris; Clinical Trials as Topic; Erythrityl Tetranitrate; Humans; Isosorbide Dinitrate; Ni | 1973 |
Effects of alprenolol and isosorbide dinitrate in angina pectoris. A comparative study with methodological considerations.
Topics: Activities of Daily Living; Adult; Aged; Alprenolol; Angina Pectoris; Electrocardiography; Female; F | 1973 |
Double-blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Exercise Test; Female; Furan | 1973 |
Comparative evaluation of sublingual long-acting nitrates.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Corona | 1973 |
[Controlled evaluation of treatment with an antianginous drug of patients with coronary disease].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Drug Evaluation; Ethanolamines; Ethylenediam | 1973 |
Action and nomenclature of nitroglycerin and nitrate esters.
Topics: Administration, Oral; Angina Pectoris; Clinical Trials as Topic; Coronary Vessels; Humans; Nitrates; | 1972 |
The long-acting hemodynamic effects of isosorbide dinitrate.
Topics: Angina Pectoris; Blood Pressure; Cardiac Output; Cardiac Volume; Exercise Test; Furans; Hemodynamics | 1972 |
Hemodynamic response of oral long-acting nitrates: evidence of gastrointestinal absorption.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Blood Flow Velocity; Clinical Trials as Topic; C | 1972 |
Effects of propranolol and isosorbide dinitrate on exercise performance and adrenergic acitivity in patients with angina pectoris.
Topics: Adrenal Glands; Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Drug Synergi | 1969 |
New dimension in angina pectoris therapy.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Drug Synergism; Electrocar | 1969 |
New drugs in the treatment of angina.
Topics: Angina Pectoris; Clinical Trials as Topic; Drug Synergism; Furans; Heart Rate; Humans; Isosorbide Di | 1969 |
Dilemmas of angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Furans; Humans; Isosorbide Dinitrate; Nitrates; Placebos; | 1969 |
[Methods o clinical evaluation of therapeutic agents for the treatment of angina pectoris].
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Dipyridamole; Electrocardiography; Female; Furans; | 1970 |
Stress tests and the evaluation of anti-anginal drugs.
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Electrocardiography; Erythrityl Tetranitrate; Eval | 1967 |
Propranolol combined with isosorbide dinitrate versus placebo in angina pectoris.
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Drug Synergism; Electrocardiography; Exercise Test | 1969 |
Evaluation of propranolol and of isosorbide dinitrate in angina pectoris.
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Furans; Humans; Isosorbide Dinitrate; Middle Aged; | 1969 |
Rapidity of the hypotensive effect of short-acting nitrous compounds.
Topics: Adolescent; Adult; Aerosols; Amyl Nitrite; Angina Pectoris; Blood Pressure; Depression, Chemical; Fe | 1969 |
Sublingual isosorbide dinitrate therapy versus sublingual acebo in angina pectoris.
Topics: Administration, Oral; Adult; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Furans; Hear | 1970 |
Evaluation of nitroglycerin in angina in patients on isosorbide dinitrate.
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Furans; Heart; Humans; Isosorbide Dinitrate; Male; | 1970 |
Therapy of angina pectoris with propranolol and long-acting nitrates.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Electrocardiography; Exercis | 1969 |
Therapy of angina pectoris with propranolol and long-acting nitrates.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Electrocardiography; Exercis | 1969 |
The effects of chewable isosorbide dinitrate in coronary insufficiency. A report on exercise electrocardiograms in 13 patients.
Topics: Administration, Oral; Aged; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; | 1971 |
Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Drug Synergism; Electrocardi | 1971 |
The 'overlap' method of comparing drugs.
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Female; Humans; Male; Methods; Middle Aged; Nitrate | 1971 |
Quantitative angiography: the measurement of coronary vasomobility in the intact animal and man.
Topics: Administration, Oral; Adult; Angina Pectoris; Angiocardiography; Animals; Cineangiography; Clinical | 1971 |
Isosorbide dinitrate in angina.
Topics: Administration, Oral; Angina Pectoris; Evaluation Studies as Topic; Furans; Humans; Isosorbide Dinit | 1971 |
Isosorbide di-nitrate in angina pectoris. A double-blind-study of 50 cases.
Topics: Adult; Aged; Angina Pectoris; Electrocardiography; Female; Furans; Humans; Isosorbide Dinitrate; Mal | 1970 |
Propranolol and isosorbide dinitrate synergism in angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Drug Synergism; Electrocardiography; Exercise Test; Female; Furans; He | 1968 |
Double blind controlled clinical trial of a long acting coronary vasodilator isosorbide dinitrate (sorbitrate).
Topics: Adult; Aged; Angina Pectoris; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitrates; Placebos | 1968 |
Dilemmas of angina pectoris.
Topics: Angina Pectoris; Digitalis Glycosides; Exercise Test; Furans; Humans; Isosorbide Dinitrate; Nitrates | 1969 |
Exercise performance and electrocardiographic changes as indices of effect of long-acting nitrates in angina pectoris.
Topics: Aged; Angina Pectoris; Delayed-Action Preparations; Electrocardiography; Exercise Test; Female; Huma | 1966 |
[An organic nitrate preparation for the treatment of chronic arterial circulation disorders of the extremities].
Topics: Angina Pectoris; Humans; Intermittent Claudication; Leg; Nitrates | 1966 |
344 other studies available for nitrates and Angina Pectoris
Article | Year |
---|---|
Summary for Patients: Risk for Unwanted Outcomes in Men Prescribed Both Drugs for Erectile Dysfunction and Nitrates for Angina.
Topics: Angina Pectoris; Erectile Dysfunction; Humans; Male; Nitrates; Vasodilator Agents | 2022 |
Prognostic impact of nitrate therapy in patients with myocardial bridge and coexisting coronary artery spasm.
Topics: Angina Pectoris; Coronary Angiography; Coronary Vasospasm; Coronary Vessels; Humans; Nitrates; Progn | 2023 |
The Relationship Between Nitrate-Induced Headache and -Blood Viscosity: An Observational Prospective Study.
Topics: Angina Pectoris; Blood Viscosity; Humans; Nitrates; Prospective Studies | 2023 |
Impact of different nitrate therapies on long-term clinical outcomes of patients with vasospastic angina: A propensity score-matched analysis.
Topics: Aged; Angina Pectoris; Cause of Death; Coronary Vasospasm; Female; Follow-Up Studies; Heart Diseases | 2018 |
Low Diastolic Blood Pressure Is Associated With Angina in Patients With Chronic Coronary Artery Disease.
Topics: Age Factors; Aged; Angina Pectoris; Blood Pressure; Body Mass Index; Cardiovascular Agents; Coronary | 2018 |
Physical Activity After Percutaneous Coronary Intervention for Chronic Total Occlusion and Its Association With Health Status.
Topics: Aged; Angina Pectoris; Cardiovascular Agents; Chronic Disease; Coronary Occlusion; Exercise; Exercis | 2019 |
Supreme dominance of right coronary artery in a patient with typical angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Coronary Angiography; Coronary Circulation; Coronary V | 2019 |
Management and outcomes of non-ST elevation acute coronary syndromes in relation to previous use of antianginal therapies (from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]).
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Aged; Angina Pectoris; Biomarkers; Calcium Cha | 2013 |
Favorable outcomes of patients with vasospastic angina associated with cardiac arrest.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Defibrillators, Implantable; Female; Follow- | 2014 |
Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Coronary Vasospasm; Female; Humans | 2015 |
Focusing on angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Congresses as Topic; Europe; | 2015 |
Nitrates are safe in patients with glaucoma.
Topics: Angina Pectoris; Comorbidity; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pre | 2015 |
Impact of Diltiazem Alone versus Diltiazem with Nitrate on Five-Year Clinical Outcomes in Patients with Significant Coronary Artery Spasm.
Topics: Acetylcholine; Aged; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Coronary Angi | 2017 |
Real-world Evidence for the Antianginal Efficacy of Trimetazidine from the Russian Observational CHOICE-2 Study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Drug Therapy, Combination; Female; Humans | 2017 |
Drugs, angioplasty nearly equal for angina relief.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon; Angiotensin II Type 1 Receptor B | 2008 |
Understanding organic nitrates--a vein hope?
Topics: Aldehyde Dehydrogenase; Angina Pectoris; Animals; Ascorbic Acid; Drug Tolerance; Mitochondria; Nitra | 2009 |
[From beta blocker to relaxation exercises. Prevention of angina pectoris attacks].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Exercise Therapy; Humans; Mo | 2011 |
Asian patients may receive inferior care.
Topics: Angina Pectoris; Asia; England; Family Practice; Health Promotion; Humans; Nitrates; Quality of Heal | 2002 |
Vasospastic angina.
Topics: Angina Pectoris; Calcium Channel Blockers; Catheterization; Coronary Stenosis; Coronary Vasospasm; D | 2003 |
[Acute coronary syndromes without ST-elevation -- treatment].
Topics: Acute Disease; Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Anticoagulants; Cardi | 2003 |
[Various forms of mononitrates in treating patients with stress angina].
Topics: Aged; Angina Pectoris; Electrocardiography; Humans; Middle Aged; Nitrates | 2003 |
Significance of asymmetric dimethylarginine (ADMA) concentrations during coronary circulation in patients with vasospastic angina.
Topics: Aged; Angina Pectoris; Arginine; Case-Control Studies; Coronary Angiography; Coronary Circulation; C | 2003 |
Repeated nitrate prescriptions as a potential marker for angina pectoris. A comparison with medical information from the Rotterdam Study.
Topics: Aged; Angina Pectoris; Drug Prescriptions; Drug Utilization; Follow-Up Studies; Forecasting; Humans; | 2003 |
[Guidelines for diagnosis and treatment of chronic coronary heart disease. Issued by the executive committee of the German Society of Cardiology--Heart Circulation Research in cooperation with the German Society for Prevention and Rehabilitation of Cardia
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Angina, Unstable; Angiotensin-Converting | 2003 |
A comparison of peritrate and other organic nitrates in the treatment of angina pectoris.
Topics: Angina Pectoris; Nikethamide; Nitrates; Pentaerythritol Tetranitrate | 1953 |
[Contribution to the therapy of angina pectoris syndrome with myocardon].
Topics: Aminophylline; Angina Pectoris; Atropine; Drug Combinations; Humans; Nitrates; Nitroglycerin; Papave | 1953 |
Penta-erythritol tetranitrate in treatment of angina.
Topics: Angina Pectoris; Blood Pressure; Electrocardiography; Erythrityl Tetranitrate; Humans; Nitrates; Rub | 1953 |
Action of triethanolamine trinitrate in angina pectoris.
Topics: Angina Pectoris; Ethanolamines; Humans; Nitrates; Nitrites | 1954 |
[Stenocardiac attacks in workers employed in production of dynamite with nitroglycols].
Topics: Angina Pectoris; Employment; Ethylene Glycols; Ethylenes; Humans; Nitrates; Nitroglycerin | 1954 |
[Neurocardin in the treatment of angina pectoris].
Topics: Angina Pectoris; Barbiturates; Humans; Nitrates; Papaverine; Theophylline | 1955 |
Metamine (triethanolamine trinitrate biphosphate) in angina pectoris.
Topics: Angina Pectoris; Ethanolamines; Nitrates; Nitrites; Vasodilator Agents | 1955 |
Triethanolamine trinitrate (metamine) in the treatment of angina pectoris; a long-term study.
Topics: Angina Pectoris; Ethanolamines; Longitudinal Studies; Nitrates; Nitrites; Vasodilator Agents | 1956 |
[Triethanolamine trinitrate in angina pectoris].
Topics: Angina Pectoris; Ethanolamines; Nitrates; Nitrites | 1956 |
[Prevention and therapy of angina pectoris syndrome; study of the effectiveness of alkyl nitrate ester].
Topics: Angina Pectoris; Esters; Nitrates; Nitrites; Nitrogen Oxides | 1956 |
Triethanolamine trinitrate biphosphate (metamine) in the treatment of angina pectoris.
Topics: Angina Pectoris; Ethanolamines; Nitrates; Nitrites; Vasodilator Agents | 1957 |
[Electrocardiographical study of effect of biphosphate of triethanolamine trinitrate in angina pectoris].
Topics: Angina Pectoris; Electrocardiography; Ethanolamines; Nitrates; Nitrites | 1956 |
New clinical approach to the management of intermittent claudication (angina cruris).
Topics: Angina Pectoris; Humans; Intermittent Claudication; Nitrates; Tranquilizing Agents | 1958 |
[Use of nitranol in stenocardia].
Topics: Angina Pectoris; Nitrates | 1958 |
The correlation of pain relief with blood nitrate levels in angina pectoris when treated with pentaerythritol tetranitrate.
Topics: Angina Pectoris; Nitrates; Nitrites; Nitrogen Oxides; Pain Management; Pentaerythritol Tetranitrate | 1961 |
A comparative trial of two prophylactic agents in angina pectoris.
Topics: Angina Pectoris; Humans; Nitrates | 1962 |
Clinical trial of sorbide nitrate, a long-acting coronary artery dilator.
Topics: Angina Pectoris; Coronary Vessels; Humans; Isosorbide Dinitrate; Nitrates; Vasodilator Agents | 1963 |
Anginal syndrome. Treatment with a long-acting nitrate (itramin tosylate).
Topics: Angina Pectoris; Humans; Nitrates; Nitrites; Nitrogen Oxides | 1963 |
Clinical evaluation of sublingual nitrates. Onset and duration of action of nitroglycerin and isosorbide dinitrate.
Topics: Angina Pectoris; Humans; Isosorbide Dinitrate; Nitrates; Nitrites; Nitroglycerin; Vasodilator Agents | 1963 |
Assay of antianginal agents. A long-acting nitrate, psychic energizers and a tranquilizer.
Topics: Angina Pectoris; Cardiovascular Agents; Chlordiazepoxide; Erythrityl Tetranitrate; Humans; Hydrazine | 1963 |
[ORGANIC NITRATES AND THEIR USE IN STENOCARDIA].
Topics: Angina Pectoris; Nitrates; Nitroglycerin | 1963 |
USE OF NITRATE AND NITRITE VASODILATORS BY GLAUCOMATOUS PATIENTS.
Topics: Angina Pectoris; Glaucoma; Humans; Nitrates; Nitrites; Nitroglycerin; Toxicology; Vasodilator Agents | 1964 |
[CLINICAL STUDY OF L-2329 IN ANGINA PECTORIS].
Topics: Angina Pectoris; Biomedical Research; Nitrates; Placebos; Vasodilator Agents | 1964 |
DRUG THERAPY IN ANGINA PECTORIS.
Topics: Alcoholic Beverages; Angina Pectoris; Drug Therapy; Hypnotics and Sedatives; Nitrates; Toxicology; T | 1964 |
[RECENT DATA CONCERNING THE USE OF NITRO DERIVATIVES IN CARDIOLOGY].
Topics: Amyl Nitrite; Angina Pectoris; Cardiology; Drug Therapy; Heart Defects, Congenital; Humans; Nitrates | 1964 |
ISOSORBIDE DI-NITRATE ("SORBITRATE')--A NEW ANTI-ANGINAL DRUG.
Topics: Angina Pectoris; Biomedical Research; Chemical Phenomena; Chemistry; Drug Therapy; Drug Tolerance; H | 1964 |
STEREO-ISOMERIC NITRATES IN THE TREATMENT OF ANGINA PECTORIS.
Topics: Angina Pectoris; Biomedical Research; Chlorothiazide; Dipyridamole; Drug Therapy; Erythrityl Tetrani | 1965 |
[ THE USE OF DIEDI NITRATE IN PREVENTION OF ANGINA ATTACKS].
Topics: Acetates; Ammonium Compounds; Angina Pectoris; Drug Therapy; Geriatrics; Humans; Nitrates; Nitrogen | 1964 |
[COMPARATIVE ANALYSIS OF THERAPEUTIC RESULTS IN THE TREATMENT OF ANGINA PECTORIS WITH ERINITE AND MANITRITE].
Topics: Angina Pectoris; Humans; Mannitol; Nitrates; Pentaerythritol Tetranitrate | 1965 |
[AN ORGANIC NITRATE PREPARATION FOR THE TREATMENT AND PREVENTION OF ANGINA PECTORIS].
Topics: Angina Pectoris; Drug Therapy; Nitrates; Nitrites; Nitrogen Oxides | 1964 |
[ANGINA PECTORIS AND NITROGLYCOL DEFICIENCY IN EXPLOSIVE FACTORIES].
Topics: Angina Pectoris; Electrocardiography; Ethylene Glycols; Glycols; Humans; Nitrates; Occupational Dise | 1965 |
Metamine treatment in angina pectoris.
Topics: Angina Pectoris; Nitrates; Vasodilator Agents | 1959 |
[Ettriol trinitrate--a new nitrate compound].
Topics: Angina Pectoris; Myocardial Infarction; Nitrates; Nitrites; Nitrogen Oxides | 1960 |
Comparative responses to various nitrates in the treatment of angina pectoris.
Topics: Angina Pectoris; Humans; Nitrates; Nitrites | 1962 |
Coexistence of familial hypertrophic cardiomyopathy and vasospastic angina pectoris in two brothers.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic, Familial; Coronary An | 2003 |
[Continuous protection against angina pectoris-like disorders. Attack prevention without a nitrate pause].
Topics: Angina Pectoris; Coronary Disease; Free Radicals; Humans; Isosorbide Dinitrate; Myocardial Infarctio | 2003 |
Successful treatment of refractory vasospastic angina with corticosteroids: coronary arterial hyperactivity caused by local inflammation?
Topics: Adrenal Cortex Hormones; Adult; Angina Pectoris; Anti-Inflammatory Agents; Asthma; Calcium Channel B | 2004 |
Periods of cluster headache induced by nitrate therapy and spontaneous remission of angina pectoris during active clusters.
Topics: Adolescent; Adult; Age of Onset; Aged; Angina Pectoris; Cluster Headache; Exercise Test; Female; Hum | 2004 |
Triethanolamine trinitrate (metamine) in the treatment of angina pectoris; a preliminary report.
Topics: Angina Pectoris; Ethanolamines; Nitrates | 1951 |
Management of patients with suspected angina, but without known myocardial infarction: a cross-sectional survey.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Cardiovascular Agents; Cross-Sectional Studies; Family Pra | 2004 |
Nitrates for chest pain linked with arthritis.
Topics: Angina Pectoris; Arthritis; Chest Pain; Female; Humans; Nitrates | 2004 |
Tolerance induction during therapy with long-acting nitrates: how extensive is the "collateral damage"?
Topics: Angina Pectoris; Delayed-Action Preparations; Drug Tolerance; Humans; In Vitro Techniques; Isosorbid | 2004 |
Alcohol in the treatment of angina pectoris.
Topics: Alcohols; Angina Pectoris; Ethanol; Humans; Nitrates | 1950 |
[Effect of trinitrates upon human circulation].
Topics: Angina Pectoris; Cardiovascular System; Ethanolamines; Humans; Nitrates | 1950 |
[Benefits and risks of nitrate preparations in the treatment of angina pectoris].
Topics: Angina Pectoris; Humans; Nitrates; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pro | 2005 |
Effectiveness of low dose denopamine, a beta1-adrenoceptor agonist, in a patient with vasospastic angina refractory to intensive medical treatment.
Topics: Adrenergic beta-Agonists; Angina Pectoris; Blood Pressure; Coronary Vasospasm; Electrocardiography; | 2006 |
Detection of aspirin resistance by PFA-100: prevalence and aspirin compliance in patients with chronic stable angina.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Case-Control Studies; Female; Humans; Male | 2005 |
Chronic stable angina.
Topics: Acetanilides; Angina Pectoris; Chronic Disease; Drug Interactions; Enzyme Inhibitors; Humans; Hypote | 2005 |
Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Benzazepines; Calcium Channel Blockers; Cardi | 2006 |
'The heart less bounding': treating angina pectoris.
Topics: Angina Pectoris; History, 19th Century; History, 20th Century; Humans; Nitrates; Nitrites; Vasodilat | 2006 |
Ranolazine (Ranexa) for chronic stable angina.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Canada; Chroni | 2007 |
[Oxygen-transport function of the blood and endothelial dysfunction in patients with angina pectoris and arterial hypertension].
Topics: Acidosis; Adult; Angina Pectoris; Endothelium, Vascular; Female; Hemoglobins; Humans; Hypertension; | 2007 |
An atypical case of typical chest pain.
Topics: Administration, Cutaneous; Administration, Sublingual; Aged; Angina Pectoris; Chest Pain; Diagnosis, | 2008 |
Drugs and the heart. II. Nitrates.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Blood Pressure; Coronary Circulation; Drug Therapy, Co | 1980 |
[Effect of a one-time dose of prolonged-action beta-adrenoblockaders and nitrates on the tolerance of physical loads in ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Coronary Disease; Delayed-Action Preparations; | 1980 |
[Some cardiological problems in high mountains. Correlation with humans in flight].
Topics: Adrenergic beta-Antagonists; Aerospace Medicine; Altitude; Angina Pectoris; Arrhythmias, Cardiac; Di | 1980 |
How medical therapy of angina pectoris differs in patients over 65.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Diabetes Complications; Digitalis Glycosides; Hu | 1980 |
[Unstable angina pectoris. Comparison: drug therapy and surgical therapy].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Coronary Artery Bypass; Huma | 1980 |
Unstable angina pectoris: medical versus surgical treatment.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium; Coronary Artery Bypass; Cost-Benefit Analysis | 1980 |
Pharmacologic treatment of stable anginal syndromes.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Humans; Nitrates; Nitroglyce | 1981 |
The management of unstable angina.
Topics: Adrenergic beta-Antagonists; Analgesics; Angina Pectoris; Anticoagulants; Coronary Angiography; Huma | 1981 |
[Medical treatment of angina pectoris - its rational basis (author's transl)].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Calcium; Coronary Angiograph | 1980 |
[How can cardiac accidents, caused by therapy with beta blockers, be prevented?].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Digitalis Glycosides; Glucag | 1981 |
Medical management of the patient with angina pectoris: an overview of the problem.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Cardiovascular Agents; Coronary Artery Bypass; Coronar | 1982 |
[Treatment of angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Humans; Nitrates; Vasodilator Agents | 1982 |
Antianginal drug therapy (1980).
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Humans; Nitrates | 1981 |
[Treatment of angina pectoris with special reference to beta-blockers].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anticoagulants; Calcium Channel Blockers; Diagnosis, D | 1982 |
Nifedipine therapy in angina pectoris: evaluation of safety and side effects.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel | 1982 |
Managing angina with beta blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Humans; Metoprolol; Nadolol; Nitrates; Propa | 1982 |
Medical management of angina: nitrates, beta blockers, calcium channel blockers.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Calciu | 1982 |
Managing angina with calcium channel blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Dr | 1982 |
Calcium channel blocking drugs for chronic, stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; H | 1982 |
Calcium channel blocking drugs for chronic, stable angina. Nifedipine.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Angina Pectoris; Dose-Response Relationship, Drug | 1982 |
Calcium channel blocking drugs for chronic, stable angina. Verapamil.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Drug Therapy, Combination; Half-Life; Hemodynamics; Hu | 1982 |
Calcium channel blocking drugs for chronic, stable angina. Diltiazem.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Diltiazem; Hemodynamics; Humans; Nitrate | 1982 |
Ventricular ectopy: etiology, evaluation, and therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Aprindine; Arrhyth | 1982 |
Effects of antianginal drugs on ventricular function, myocardial blood flow and peripheral circulation.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Blood Circulation; Calcium Channel Blockers; Diltiazem | 1982 |
[Unstable angina: current therapeutic approach].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Coronary Artery Bypass; Coro | 1982 |
[Frequent errors in the therapy of heart disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biologic | 1982 |
[Angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Humans; Nitrates | 1983 |
Titrates for treatment of unstable angina pectoris and coronary vasospasm.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Blood Pressure; Calcium Chan | 1983 |
Recent advances in the medical treatment of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Humans; Nitrates | 1983 |
Effect of nifedipine alone versus in combination with beta blockers and/or nitrates on left ventricular function in angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Humans; Nifedipine; Nitrates | 1983 |
The treacherous waters of unstable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; E | 1983 |
Rational medical therapy for stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Heart | 1984 |
[Unstable angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Humans; Ni | 1984 |
Nitrates and angina.
Topics: Angina Pectoris; Angina, Unstable; Coronary Circulation; Coronary Vessels; Humans; Nitrates; Vasodil | 1984 |
Calcium blockers in angina. How they work, when to prescribe.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular System; Coron | 1984 |
Medical management of patients with angina. Has first-line management changed?
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Blood Pressure; Calcium Chan | 1984 |
Medical management of coronary heart disease: cardiovascular drug therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Coron | 1984 |
[Unstable angina caused by monotruncular stenosis of the anterior interventricular artery (87 cases). Results of medical and surgical treatment].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Anticoagulants; Calcium Channel Bloc | 1984 |
[Differential ambulatory treatment of patients with various forms of ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Ambulatory Care; Angina Pectoris; Calcium Channel Blockers; Coron | 1984 |
[Functional dynamics of ischemic heart disease patients with stable stenocardia as affected by drug treatment].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Coronary Angiography; Coronary Disease; Delayed | 1984 |
Medical management of stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; H | 1984 |
[Therapy of angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Angina, Unstable; Calcium Ch | 1984 |
[Diagnosis and drug therapy in the postinfarct phase].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium | 1984 |
Calcium antagonists, nitrates, and new antianginal drugs.
Topics: Angina Pectoris; Calcium Channel Blockers; Humans; Hypertension; Isosorbide Dinitrate; Lidoflazine; | 1983 |
Nitroglycerin and long-acting nitrates in clinical practice.
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Vasospasm; Drug Tolerance; Heart Failure; Humans | 1983 |
Methemoglobin levels produced by organic nitrates in patients with coronary artery disease.
Topics: Aged; Angina Pectoris; Angina, Unstable; Coronary Disease; Female; Humans; Isosorbide Dinitrate; Mal | 1984 |
Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance.
Topics: Angina Pectoris; Drug Tolerance; Electrocardiography; Hemodynamics; Humans; Isosorbide Dinitrate; Lo | 1984 |
Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20): a multi-centre study in hospital and general practice.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Electrocardiography; Exercise Test; Female; Heart Ra | 1984 |
[Studies on the relation between collateral development and the effects of antianginal drugs--effects of nitroglycerin and 2-nicotinamidethyl nitrate on collateral circulation (author's transl)].
Topics: Angina Pectoris; Animals; Collateral Circulation; Coronary Circulation; Dogs; Niacinamide; Nicorandi | 1981 |
Effects of N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) on methacholine-induced ECG changes in intact anesthetized rats.
Topics: Acetylcholine; Anesthesia; Angina Pectoris; Animals; Blood Pressure; Brain; Electrocardiography; Hea | 1981 |
Nitrates in heart disease.
Topics: Angina Pectoris; Heart Diseases; Heart Failure; Humans; Nitrates; Vasodilator Agents | 1984 |
[Tolerance for the antianginal effect of nitrates. Approaches to its study].
Topics: Angina Pectoris; Chronic Disease; Coronary Disease; Delayed-Action Preparations; Dose-Response Relat | 1984 |
The effect of nitrate on the oxygen availability during exercise in effort angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Biological Availability; Blood Pressure; Electrocardiography; Energy M | 1984 |
[Tolerance or hemodynamic adaptation during nitrate therapy].
Topics: Adaptation, Physiological; Angina Pectoris; Drug Tolerance; Hemodynamics; Humans; Isosorbide Dinitra | 1984 |
Long-term prognosis of "variant" angina with medical treatment.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Arteriosclerosis; Coro | 1980 |
Nitrate tolerance and dependence. A critical assessment.
Topics: Angina Pectoris; Animals; Dogs; Drug Tolerance; Heart Failure; Humans; Isosorbide Dinitrate; Nitrate | 1980 |
[Long-term use of nitrates in angina pectoris. Is there a development of tolerance?].
Topics: Administration, Oral; Angina Pectoris; Drug Tolerance; Humans; Nitrates; Nitroglycerin; Occupational | 1980 |
[Modern aspects of nitro preparation use].
Topics: Adult; Aged; Angina Pectoris; Cardiovascular Agents; Chronic Disease; Coronary Disease; Delayed-Acti | 1980 |
[Use of nitrates in clinical practice].
Topics: Angina Pectoris; Cardiovascular System; Electrocardiography; Heart Failure; Humans; Myocardial Infar | 1980 |
Verapamil therapy in variant angina pectoris refractory to nitrates.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Electrocardiography; Ergonovine; Female; Hum | 1981 |
Nitrates, package inserts, and the Food and Drug Administration. A clinical paradox.
Topics: Angina Pectoris; Biological Availability; Delayed-Action Preparations; Drug Labeling; Heart Failure; | 1981 |
The nitrites and nitrates.
Topics: Angina Pectoris; Angina Pectoris, Variant; Drug Interactions; Ethanol; Heart Failure; Liver; Mouth F | 1982 |
Managing angina with nitrates.
Topics: Administration, Oral; Administration, Topical; Angina Pectoris; Angina Pectoris, Variant; Capsules; | 1982 |
[Serum nitrate levels in patients with stable angina pectoris treated with sustained-action nitroglycerin preparations].
Topics: Adult; Angina Pectoris; Delayed-Action Preparations; Humans; Male; Middle Aged; Nitrates; Nitroglyce | 1982 |
[Clinical efficacy of nitrates in the treatment of exertional angina pectoris].
Topics: Acute Disease; Angina Pectoris; Heart Rate; Heart Ventricles; Humans; Long-Term Care; Nitrates; Phys | 1982 |
Orally administered nitrates in patients with exertional angina.
Topics: Administration, Oral; Angina Pectoris; Humans; Nitrates; Physical Exertion | 1983 |
Pathogenesis of angina pectoris and role of nitrates in relief of myocardial ischemia.
Topics: Angina Pectoris; Angina Pectoris, Variant; Blood Platelets; Coronary Vasospasm; Coronary Vessels; Hu | 1983 |
Tolerance to organic nitrates: clinical and experimental perspectives.
Topics: Angina Pectoris; Animals; Dogs; Dose-Response Relationship, Drug; Drug Tolerance; Heart Failure; Hem | 1983 |
[Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 4. 1.Nitrite-containing angina pectoris agents].
Topics: Angina Pectoris; Humans; Nitrates | 1980 |
Exercise induced non ischemic angina pectoris due to abnormal left ventricular compliance.
Topics: Adult; Angina Pectoris; Angiography; Exercise Test; Female; Heart Ventricles; Hemodynamics; Humans; | 1981 |
Unstable angina pectoris: therapeutic choices.
Topics: Angina Pectoris; Coronary Artery Bypass; Coronary Vessels; Electrocardiography; Humans; Intra-Aortic | 1980 |
Management of unstable angina pectoris.
Topics: Angina Pectoris; Arterial Occlusive Diseases; Cardiac Surgical Procedures; Coronary Artery Bypass; C | 1981 |
Increased plasma concentrations of platelet factor 4 in coronary artery disease: a measure of in vivo platelet activation and secretion.
Topics: Angina Pectoris; Calcium; Cholesterol; Coronary Artery Bypass; Coronary Disease; Drug Therapy, Combi | 1981 |
[Therapy of angina pectoris. Pharmacologic basis of therapy with organic nitrates].
Topics: Angina Pectoris; Chemical Phenomena; Chemistry; Drug Tolerance; Heart; Humans; Kinetics; Nitrates | 1982 |
[High-dose nitrate therapy in angina pectoris and cardiac insufficiency].
Topics: Angina Pectoris; Dose-Response Relationship, Drug; Heart Failure; Humans; Nitrates; Oxygen Consumpti | 1982 |
Efficacy of nifedipine in rest angina refractory to propranolol and nitrates in patients with obstructive coronary artery disease.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged | 1981 |
[Treatment with nitrate depot preparations and calcium antagonists].
Topics: Angina Pectoris; Calcium; Delayed-Action Preparations; Heart Failure; Humans; Nitrates | 1981 |
Platelet activation during exercise-induced myocardial ischemia.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Aspirin; Blood Coagulation Factors; Blood Platelets; Child | 1980 |
[Habituation to nitrates. A response to V. Wandner's paper "The Angina Pectoris Syndrome" in Z. ärztl. Fortbild. 73(1979), p. 58--At the same time a presentation of the current state of knowledge].
Topics: Angina Pectoris; Humans; Nitrates; Substance-Related Disorders | 1980 |
[Therapeutic aspects of a case of Prinzmetal's angina].
Topics: Aged; Amiodarone; Angina Pectoris; Angina Pectoris, Variant; Drug Therapy, Combination; Electrocardi | 1980 |
The rationale for nitrates in angina pectoris.
Topics: Angina Pectoris; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Isos | 1995 |
New antianginal nitro esters with reduced hypotensive activity. Synthesis and pharmacological evaluation of 3-[(nitrooxy)alkyl]-2H-1,3-benzoxazin-4(3H)-ones.
Topics: Angina Pectoris; Animals; Benzoxazines; Blood Pressure; Hemodynamics; Hypotension; In Vitro Techniqu | 1995 |
Emerging options in the management of myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Coronary Disease | 1994 |
[The single-dose screening of nitrates, calcium antagonists, beta-adrenoblockaders and their combinations in patients with stenocardia of effort by using the paired bicycle ergometry method].
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Angina Pectoris; Calcium Channel Blockers; Chroni | 1993 |
The pharmacological management of angina pectoris.
Topics: Administration, Sublingual; Adrenergic beta-Antagonists; Angina Pectoris; Humans; Nitrates; Risk Fac | 1993 |
[Nitrates in the treatment of chronic stable angina].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium; Chronic Disease; Drug Therapy, Combination; H | 1993 |
[The effect of pyridinolcarbamate (parmidine) on the microcirculation and immunity of patients with stable angina].
Topics: Angina Pectoris; Antibody Formation; Autoimmunity; Drug Evaluation; Drug Therapy, Combination; Human | 1993 |
[Nitrate derivatives. Principles and rules of use].
Topics: Angina Pectoris; Coronary Disease; Humans; Nitrates | 1993 |
Implication of prescriptions for nitrates: 7 year follow up of patients treated for angina in general practice.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Cardiology Service, Hospital; Cause of Death; Engla | 1994 |
[The efficacy of nitrate solutions in emergency states].
Topics: Angina Pectoris; Drug Evaluation; Emergencies; Humans; Infusions, Intravenous; Isosorbide Dinitrate; | 1993 |
[Medical treatment of patients with stable angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Calcium Chan | 1995 |
[Antianginal therapy '95].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Calcium Chan | 1996 |
[Nitrates--1996 current therapy concept?].
Topics: Angina Pectoris; Coronary Disease; Humans; Nitrates; Vasodilator Agents | 1996 |
[Features of the course of silent myocardial ischemia and choice of therapeutic policy].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Calcium Channel Blockers; Coronary Angiography; | 1996 |
Current approaches to stable angina.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Aspirin; Humans; Hypolipidemic Agents; Middle Ag | 1996 |
Methodology for assessing the prevalence of angina in primary care using practice based information in northern England.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Child; Child, Preschool; Cross-Sectional Studies; Drug Pre | 1997 |
Treatment of medically and surgically refractory angina pectoris with high thoracic epidural analgesia: initial clinical experience.
Topics: Adrenergic beta-Antagonists; Analgesia, Epidural; Analgesics; Analgesics, Opioid; Anesthetics, Local | 1997 |
Nitroglycerin tolerance at the platelet level in patients with angina pectoris.
Topics: Administration, Sublingual; Angina Pectoris; Angina, Unstable; Blood Platelets; Drug Tolerance; Guan | 1997 |
Long-lasting abnormalities in cardiac sympathetic nervous system in patients with coronary spastic angina: quantitative analysis with iodine 123 metaiodobenzylguanidine myocardial scintigraphy.
Topics: 3-Iodobenzylguanidine; Acetylcholine; Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Corona | 1997 |
Antianginal therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Dental Care for Chronically | 1995 |
[Therapy recommendations for adverse effects of Viagra and nitrates (NO-donors)].
Topics: Angina Pectoris; Blood Pressure; Contraindications; Drug Therapy, Combination; Erectile Dysfunction; | 1998 |
Medical therapy after successful percutaneous coronary revascularization.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel | 1999 |
Cost-effectiveness study of nitrate therapy using a decision analysis methodology.
Topics: Angina Pectoris; Cost-Benefit Analysis; Decision Support Techniques; Drug Administration Routes; Dru | 1994 |
Nitrate resistance in platelets from patients with stable angina pectoris.
Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Blood Platelets; Drug Resistance; Female; Human | 1999 |
Nitric oxide metabolites in decompensated liver cirrhosis.
Topics: Adult; Aged; Angina Pectoris; Female; Hemoglobins; Humans; Kidney Failure, Chronic; Liver Cirrhosis; | 1999 |
Medical therapy for stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Humans; Meta-Analysis as Top | 1999 |
Intensity of antianginal therapy in patients referred for coronary angiography: a comparison of fee-for-service and health maintenance organization therapeutic strategies.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel | 2000 |
[Role of nitrates in the treatment of ischemia].
Topics: Angina Pectoris; Coronary Disease; Emergencies; Humans; Hypotension, Orthostatic; Isosorbide Dinitra | 2000 |
[Development of nitrate tolerance].
Topics: Angina Pectoris; Animals; Drug Tolerance; Humans; Molsidomine; Nitrates; Vasodilator Agents | 2000 |
Is steroid deficiency the cause of tolerance in nitrate therapy?
Topics: Angina Pectoris; Animals; Drug Tolerance; Feedback; Genitalia, Male; Humans; Male; Models, Biologica | 2000 |
Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T-->C mutation associated with coronary spastic angina.
Topics: Alleles; Amino Acid Sequence; Angina Pectoris; Animals; Base Sequence; Cell Line; DNA-Binding Protei | 2000 |
Diltiazem-mediated inhibition of sildenafil metabolism may promote nitrate-induced hypotension.
Topics: Aged; Angina Pectoris; Coronary Angiography; Diltiazem; Humans; Hypotension; Male; Nitrates; Phospho | 2000 |
Guidelines for the management of patients with chronic stable angina: treatment.
Topics: Adrenergic beta-Antagonists; Adult; Algorithms; Angina Pectoris; Aspirin; Calcium Channel Blockers; | 2001 |
Appropriateness of nitrate use in a general medicine population.
Topics: Administration, Sublingual; Aged; Angina Pectoris; Cardiovascular Agents; Drug Prescriptions; Drug U | 2001 |
[Problems of combined therapy with cardiac glycosides and anti-anginal drugs (author's transl)].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Cardiac Glycosides; Coronary Disease; Drug Therapy, Co | 1977 |
Diagnosis and management of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Cardiac Catheterization; Coronary Vessels; Echocardiog | 1977 |
Hemodynamic factors and indirect assessment of myocardial oxygen consumption in the therapy of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Blood Pressure; Coronary Artery Bypass; Coronary Circu | 1977 |
[Prinzmetal's angina. Considerations on a clinical case].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Angina Pectoris, Variant; Aspirin; Electrocardi | 1977 |
Unstable angina: comparison of medical and surgical management.
Topics: Angina Pectoris; Clinical Enzyme Tests; Coronary Angiography; Coronary Artery Bypass; Electrocardiog | 1977 |
[2. International Symposium on Nitrates; Berlin 1-3 June 1978. Nitrate-effect on the heart and circulation].
Topics: Angina Pectoris; Animals; Blood Circulation; Coronary Disease; Heart; Heart Failure; Humans; Isosorb | 1978 |
Clinical indicators of left main coronary artery disease in unstable angina.
Topics: Angina Pectoris; Angiography; Anticoagulants; Calcinosis; Cardiac Catheterization; Cardiomegaly; Col | 1979 |
[Letter: Physiopathology of angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Coronary Circulation; Energy Metabolism; Humans; Myoca | 1975 |
Helping the client with unstable angina.
Topics: Angina Pectoris; Electrocardiography; Humans; Life Style; Myocardial Infarction; Nitrates; Patient E | 1978 |
Treatment of impending myocardial infarction (medical viewpoint).
Topics: Angina Pectoris; Coronary Artery Bypass; Coronary Vessels; Humans; Myocardial Infarction; Nitrates; | 1977 |
Observations on unstable angina pectoris with particular respect to management.
Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Artery Bypass; Female; Follow-Up Studie | 1979 |
Medical management of angina pectoris.
Topics: Angina Pectoris; Diet; Dose-Response Relationship, Drug; Humans; Nitrates; Nitroglycerin; Propranolo | 1977 |
Drug management of stable angina pectoris.
Topics: Angina Pectoris; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Physical Exertion; Propranol | 1977 |
[Therapy of angina pectoris].
Topics: Angina Pectoris; Humans; Nitrates | 1979 |
The metabolic demand and oxygen supply of the heart: physiologic and clinical considerations.
Topics: Aerobiosis; Angina Pectoris; Animals; Dogs; Heart; Heart Rate; Humans; Myocardial Contraction; Myoca | 1979 |
Contemporary medical management of stable angina pectoris.
Topics: Angina Pectoris; Drug Evaluation; Drug Therapy, Combination; Humans; Nitrates; Physical Education an | 1978 |
Unstable coronary artery disease: comparison of medical and surgical treatment.
Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Delaye | 1975 |
Long-acting nitrates in the treatment of angina pectoris.
Topics: Angina Pectoris; Delayed-Action Preparations; Erythrityl Tetranitrate; Hemodynamics; Humans; Isosorb | 1976 |
The responsibility to report occupational health risks.
Topics: American Medical Association; Angina Pectoris; Chemical Industry; Environmental Exposure; Ethical Re | 1977 |
New approaches to resolving diagnostic problems in patients with angina pectoris.
Topics: Angina Pectoris; Angina Pectoris, Variant; Angiography; Coronary Vessels; Echocardiography; Electroc | 1977 |
Oral nitrate therapy in coronary artery disease.
Topics: Administration, Oral; Angina Pectoris; Blood Pressure; Coronary Disease; Humans; Isosorbide Dinitrat | 1977 |
Coronary arterial surgery in patients with incapacitating angina pectoris and myxedema.
Topics: Aged; Angina Pectoris; Cardiac Catheterization; Coronary Vessels; Female; Heart Ventricles; Humans; | 1977 |
Letter: Efficacy of long-acting nitrates. I. sublingual versus oral administration.
Topics: Administration, Oral; Angina Pectoris; Animals; Dogs; Humans; Inactivation, Metabolic; Nitrates; Ton | 1976 |
[Drugs administered in angina pectoris].
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Humans; Nitrates; Sympatholytics; Vasodilator Agents | 1976 |
Syncope in association with Prinzmetal variant angina.
Topics: Angina Pectoris; Cardiac Output; Coronary Angiography; Female; Heart Block; Heart Ventricles; Humans | 1975 |
[Recognition of reversible asynergic myocardial regions through quantitative analysis of the left ventricle cineangiogram prior to and following administration of nitrates].
Topics: Angina Pectoris; Cineangiography; Heart Ventricles; Humans; Middle Aged; Nitrates | 1975 |
[Therapy of coronary disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Clinical Trials as | 1992 |
[Hyperbaric oxygenation and antianginal agents: effects on blood levels of malondialdehyde and activities of antioxidative enzymes in patients with ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Combined Modality Therapy; Female; Glutathione P | 1992 |
The treatment of stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel Blocke | 1992 |
[The individual choice of anti-anginal preparations by using paired bicycle ergometry tests in patients with stenocardia].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents | 1992 |
"Oesophageal angina" in patients with angina pectoris: a possible side effect of chronic therapy with nitroderivates and Ca-antagonists.
Topics: Aged; Angina Pectoris; Chest Pain; Diagnosis, Differential; Female; Gastroesophageal Reflux; Humans; | 1992 |
[Angina pectoris--preliminary stage to a myocardial infarct].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon, Coronary; Angioplasty, Laser; Ca | 1991 |
[Anti-ischemia drug therapy].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Fibri | 1991 |
[The efficacy of foridon in treating stenocardia patients].
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Drug Evaluation; Drug Therapy, Combination; | 1991 |
[New-onset angina pectoris: clinical aspects, diagnosis, prognosis and treatment tactics].
Topics: Angina Pectoris; Aspirin; Calcium Channel Blockers; Electrocardiography; Exercise Test; Humans; Midd | 1991 |
Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Calcium Channel Blockers; Circadian Rhythm; Coro | 1990 |
Transcutaneous electrical nerve stimulation (TENS) for treatment of severe angina pectoris refractory to maximal medical and surgical management--a case report.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel | 1990 |
[Helium-neon laser therapy in the combined treatment of unstable stenocardia].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Combined M | 1990 |
Intermittent nitrate transdermal therapy.
Topics: Administration, Topical; Angina Pectoris; Drug Administration Schedule; Humans; Legislation, Drug; N | 1990 |
[Angina pectoris--drug therapy and costs in a medical outpatient clinic in Switzerland].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Calcium Channel Blocke | 1990 |
[The effect of a diet enriched with omega-3 polyunsaturated fatty acids on thrombocyte functional activity and on the blood lipid-apolipoprotein spectrum in newly occurring stenocardia].
Topics: Adult; Angina Pectoris; Apolipoproteins; Blood Platelets; Combined Modality Therapy; Delayed-Action | 1990 |
[Expediency of long-term anti-angina therapy and physical exercises in patients with angina pectoris and a history of myocardial infarction].
Topics: Adult; Angina Pectoris; Aspirin; Exercise Therapy; Humans; Male; Middle Aged; Myocardial Infarction; | 1990 |
The esophagus as a possible cause of chest pain in patients with and without angina pectoris.
Topics: Angina Pectoris; Calcium Channel Blockers; Chest Pain; Electrocardiography, Ambulatory; Esophageal M | 1990 |
The daily profile of ventricular premature beats in the patients with ischemic heart disease.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Cardiac Complexes, Premature; Coronary Angiography; | 1987 |
Effectiveness of interval nitrate therapy in angina pectoris.
Topics: Administration, Cutaneous; Angina Pectoris; Drug Administration Schedule; Drug Tolerance; Humans; Is | 1989 |
[Evaluation of the antianginal efficacy of sustonit compared with other nitrate drug forms].
Topics: Adult; Angina Pectoris; Coronary Disease; Delayed-Action Preparations; Drug Evaluation; Exercise Tes | 1989 |
[The efficacy of prolonged-action nitrates in stenocardia].
Topics: Adult; Angina Pectoris; Delayed-Action Preparations; Drug Evaluation; Female; Humans; Male; Middle A | 1989 |
[The effect of nitrates and miskleron on the prostacyclin-thromboxane ratio and on the functional activity of the thrombocytes in stenocardia patients].
Topics: Angina Pectoris; Blood Platelets; Clofibrate; Drug Evaluation; Drug Therapy, Combination; Epoprosten | 1989 |
Nitrate tolerance and its consequences for the clinician.
Topics: Angina Pectoris; Animals; Drug Tolerance; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin | 1989 |
[Therapeutic tolerance with derivative nitrates].
Topics: Angina Pectoris; Animals; Drug Tolerance; Heart Failure; Humans; Nitrates; Nitroglycerin | 1989 |
Managing angina in the elderly: an update.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Calcium Channel Blockers; Humans; Male; Nitrates | 1989 |
[Therapy and compliance in angina pectoris--analysis of a physician and patient survey].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Austria; Calcium Channel Blockers; Drug Administ | 1989 |
Significance of coronary artery tone in patients with vasospastic angina.
Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Vasospasm; Coronary Vessels; Electrocar | 1989 |
[Hemosorption in the treatment of patients with ischemic heart disease and drug-resistant stenocardia].
Topics: Aged; Angina Pectoris; Coronary Disease; Drug Resistance; Hemoperfusion; Humans; Middle Aged; Nitrat | 1989 |
Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Drug Therapy, | 1985 |
Recent advances in drug therapy for coronary artery disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Coronary V | 1985 |
The medical therapy of angina pectoris--with an eye on cost.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Humans; Ni | 1985 |
Comparisons and combinations in anti-anginal therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Coronary Circulation; Drug T | 1985 |
Efficacy of diltiazem for medically refractory stable angina: long-term follow-up.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Benzazepines; Blood Pressure; Coronary Ar | 1985 |
[Methods of diagnosing unstable stenocardia and monitoring its treatment].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Cold Temperature; Drug Therapy, Comb | 1985 |
[Screening of single doses of nitrates, calcium antagonists and beta-adrenoblockaders in patients with stenocardia of effort by using pharmacodynamic treadmill studies].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Drug | 1985 |
[Mono- or combination therapy with myocardial and coronary active drugs in ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Drug Thera | 1985 |
[Pharmacological combinations in the treatment of exertion angina. I].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; H | 1986 |
[Results of the conservative treatment of patients with unstable stenocardia].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Angina, Unstable; Calcium Channel Blocker | 1986 |
[Current drug therapy of chronic ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Coronary Di | 1986 |
[Effect of the complex treatment of stable stenocardia on the status of the prostacyclin-thromboxane system].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Aspirin; Dipyridamole; Drug Therapy, Comb | 1986 |
Rational management following diagnosis of myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Calcium Channel Blockers; Coronary Artery Bypass | 1986 |
The pharmacologic management of coronary artery disease in 1986.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Calcium Channel Blockers; Coronary Disease | 1986 |
Stepped-care therapy for angina pectoris?
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Hemodynamics; Humans; Nitrat | 1986 |
Advances in the pharmacologic management of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; H | 1986 |
Current perspectives in treatment of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon; Calcium Channel Blockers; Corona | 1986 |
Management of unstable angina pectoris with maximal medical treatment (combination of intravenous nitrates, beta-blockers, calcium antagonists and heparin).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Angina, Unstable; Calcium Channel Blocker | 1985 |
Angina pectoris--medical treatment.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Angina, Unstable; Calcium Ch | 1986 |
Angina pectoris early after myocardial infarction: clinical experience of the multicentre post-infarction program.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Electrocardiography; Exercise Test; Humans; Long | 1986 |
Your CE topic this month (No. 21). Current angina treatment.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Humans; Nitrates; Nursing, P | 1987 |
Effective drugs in preventing recurrent coronary events. II. Late management.
Topics: Adrenergic beta-Antagonists; Ambulatory Care; Angina Pectoris; Anti-Arrhythmia Agents; Anticoagulant | 1986 |
[Comparative evaluation of the results of conservative and surgical treatment of unstable angina at long-term follow-up].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Coronary A | 1987 |
Outpatient management of coronary artery disease.
Topics: Adrenergic beta-Antagonists; Aged; Ambulatory Care; Angina Pectoris; Calcium Channel Blockers; Coron | 1987 |
[Drugs in angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Human | 1987 |
[Various theories on the pharmacological treatment of stable exercise-induced angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Calcium Channel Blockers; Huma | 1987 |
Use of percutaneous transluminal coronary angioplasty and bypass surgery despite improved medical therapy for unstable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Aspirin; Calci | 1988 |
Prevalence of angina as assessed by a survey of prescriptions for nitrates.
Topics: Aged; Angina Pectoris; Drug Prescriptions; England; Epidemiologic Methods; Female; Humans; Male; Mid | 1988 |
Angina in general practice.
Topics: Angina Pectoris; Family Practice; Humans; Nitrates | 1988 |
[Stable angina pectoris; why has the prognosis changed so much?].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Coronary Artery Bypass; Huma | 1988 |
[New possibilities for the diagnosis and therapy of ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiocardiography; Angioplasty, Balloon; Calcium Chann | 1988 |
Indices of angina.
Topics: Adult; Aged; Angina Pectoris; England; Health Status Indicators; Humans; Male; Middle Aged; Nitrates | 1988 |
Anti-anginal drugs: calcium channel blockers, beta-adrenergic blockers and nitrates.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; H | 1988 |
Clinical relevance of nitrate hemodynamic attenuation.
Topics: Administration, Topical; Angina Pectoris; Coronary Disease; Hemodynamics; Humans; Isosorbide Dinitra | 1986 |
Comparison of transdermal nitroglycerin therapy with previous long-acting oral or ointment nitrate therapy.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Aged, 80 and over; Angina Pectoris; An | 1987 |
Nitrate therapy in stable angina pectoris.
Topics: Angina Pectoris; Bradycardia; Humans; Hypotension; Nitrates; Nitroglycerin; Substance Withdrawal Syn | 1988 |
Nitrates: the problem of tolerance.
Topics: Angina Pectoris; Drug Tolerance; Heart Failure; Humans; Isosorbide Dinitrate; Nitrates; Nitroglyceri | 1988 |
Nitrate tolerance--a therapeutic dilemma.
Topics: Angina Pectoris; Captopril; Coronary Disease; Drug Therapy, Combination; Drug Tolerance; Humans; Nit | 1988 |
Management of angina pectoris.
Topics: Angina Pectoris; Angioplasty, Balloon; Calcium Channel Blockers; Combined Modality Therapy; Coronary | 1985 |
[Use of decimeter microwaves and drugs in patients with unstable stenocardia].
Topics: Angina Pectoris; Angina, Unstable; Combined Modality Therapy; Delayed-Action Preparations; Drug Ther | 1987 |
[Clinical effectiveness of plasmapheresis in patients with unstable stenocardia refractory to drug therapy].
Topics: Adolescent; Adult; Aged; Angina Pectoris; Angina, Unstable; Humans; Middle Aged; Nitrates; Plasmaphe | 1987 |
T. Lauder Brunton and amyl nitrite: a Victorian vasodilator.
Topics: Angina Pectoris; Bibliographies as Topic; Blood Pressure; History, 19th Century; History, 20th Centu | 1986 |
[Tolerance to nitrates].
Topics: Angina Pectoris; Animals; Dogs; Drug Tolerance; Exercise Test; Hemodynamics; Humans; Nitrates; Rats | 1986 |
[Is nitrates contraindication for the angina pectoris patients complicated with glaucoma?].
Topics: Aged; Angina Pectoris; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Nitrates | 1987 |
Mononitrates as monotherapy in the prophylactic treatment of angina pectoris.
Topics: Angina Pectoris; Delayed-Action Preparations; Humans; Isosorbide Dinitrate; Nitrates | 1987 |
[Bicycloalkanol nitrates].
Topics: Angina Pectoris; Animals; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Chemical Phenomena; Che | 1987 |
[Selection and combination of anti-angina drugs].
Topics: Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; Hemodynamics; Humans; Nitrates | 1987 |
[Nitrate therapy and tolerance].
Topics: Angina Pectoris; Coronary Circulation; Drug Tolerance; Electrocardiography; Hemodynamics; Humans; Mu | 1986 |
Clinical patterns of angina pectoris. How pathophysiology determines therapy.
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Humans; Nitrates | 1986 |
Nitrates in the treatment of angina.
Topics: Angina Pectoris; Humans; Nitrates | 1986 |
Nitrates V. New aspects of mechanism of action and of therapeutic application.
Topics: Angina Pectoris; Animals; Cardiovascular System; Heart Diseases; Humans; Nitrates | 1986 |
[Strategies in the medical treatment of angina pectoris].
Topics: Angina Pectoris; Humans; Monitoring, Physiologic; Nitrates | 1985 |
[Nitrate derivatives. Pharmacology].
Topics: Angina Pectoris; Blood Pressure; Heart Failure; Hemodynamics; Humans; Nitrates | 1985 |
[Therapy with nitrate derivatives].
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Disease; Humans; Myocardial Infarction; Nitrates | 1985 |
[Value of nitrates in modern coronary therapy].
Topics: Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Thera | 1985 |
Retrospective post-marketing surveillance of Transiderm-Nitro 5 in general practice in the United Kingdom.
Topics: Administration, Topical; Adult; Aged; Angina Pectoris; Calcium; Drug Therapy, Combination; Family Pr | 1985 |
[Problems in long-term preventive treatment of angina pectoris using nitrates].
Topics: Administration, Topical; Angina Pectoris; Biological Availability; Delayed-Action Preparations; Drug | 1985 |
Mechanisms and therapy of silent myocardial ischemia and the effect of transdermal nitroglycerin.
Topics: Administration, Topical; Angina Pectoris; Coronary Disease; Electrocardiography; Humans; Nitrates; N | 1985 |
Nitrate tolerance.
Topics: Administration, Topical; Angina Pectoris; Blood Pressure; Drug Tolerance; Exercise Test; Hemodynamic | 1985 |
Pharmacology of the nitrates in angina pectoris.
Topics: Administration, Oral; Administration, Topical; Angina Pectoris; Cheek; Chemical Phenomena; Chemistry | 1985 |
[Hemodynamic aspects of differential therapy of acute myocardial infarct with nitrates].
Topics: Angina Pectoris; Blood Pressure; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Infusions, P | 1985 |
Nitrate therapy for ischaemic heart disease.
Topics: Angina Pectoris; Angina, Unstable; Coronary Circulation; Coronary Disease; Drug Tolerance; Humans; M | 1985 |
[Use of verapamil for treating patients with unstable stenocardia].
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Angina, Unstable; Delayed-Action Preparations; D | 1985 |
Intraaortic balloon pumping for control of recurrent myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiography; Assisted Circulation; Blood Pressure; Cor | 1973 |
Drugs for angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Delayed-Action Preparations; Humans; Nitrates; Nitrogl | 1974 |
The nature of treatment selection in coronary artery disease. Experience with medical and surgical treatment of a chronic disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Chronic Disease; Coronary Artery Bypass; Coronary Dise | 1974 |
Medical management of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Humans; Nitrates; Nitroglycerin | 1974 |
[High-altitude hypoxia as a hypothetical method of treatment of angina pectoris].
Topics: Adrenergic beta-Antagonists; Altitude; Angina Pectoris; Animals; Coronary Artery Bypass; Coronary Ci | 1974 |
Unstable angina.
Topics: Angina Pectoris; Anticoagulants; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Ele | 1973 |
[Therapy of angina pectoris. II. Evaluation of antianginous drugs. Nitrites and nitrates].
Topics: Amyl Nitrite; Angina Pectoris; Drug Evaluation; Humans; Isosorbide Dinitrate; Mannitol; Nitrates; Ni | 1974 |
[Drug therapy of angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anticoagulants; Humans; Nitrates; Nitroglycerin; Oxyge | 1971 |
The treatment of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Nitrates; Nitrites | 1971 |
[Therapy of angina pectoris in the rehabilitation procedure].
Topics: Adult; Angina Pectoris; Exercise Test; Female; Humans; Male; Middle Aged; Nitrates | 1974 |
The influence of the thyroid on the acute toxicity of a dynamite-sensitizing mixture.
Topics: Angina Pectoris; Animals; Epinephrine; Glycols; Hyperthyroidism; Hypothyroidism; Lethal Dose 50; Mal | 1972 |
Organic nitrates: relationship between biotransformation and rational angina pectoris therapy.
Topics: Angina Pectoris; Animals; Biotransformation; Carbon Isotopes; Furans; Humans; Isosorbide Dinitrate; | 1972 |
Medical treatment of angina pectoris. 3. Pharmacology of sublingual nitrites as antianginal drugs.
Topics: Angina Pectoris; Blood Flow Velocity; Blood Vessels; Dipyridamole; Furans; Heart; Hemodynamics; Huma | 1972 |
Oral nitrates: efficacious?
Topics: Administration, Oral; Angina Pectoris; Humans; Newspapers as Topic; Nitrates | 1973 |
[Breakdown of organic nitrates in liver. Few arguments against oral administration of nitro compounds in angina pectoris].
Topics: Administration, Oral; Angina Pectoris; Humans; Liver; Nitrates; Nitro Compounds | 1973 |
Practical aspects of clinical and psyco-social problems of rehabilitation of cardiac patient: introductory remarks.
Topics: Adult; Angina Pectoris; Arrhythmias, Cardiac; Digitalis Glycosides; Disability Evaluation; Dyspnea; | 1973 |
Clinical and cardiographic evaluation of a new nitrate, itramin tosylate.
Topics: Adult; Angina Pectoris; Heart Function Tests; Humans; Middle Aged; Nitrates | 1967 |
A preliminary study of time activity of chloroglyceryl dinitrate.
Topics: Angina Pectoris; Cardiac Output; Chlorine; Coronary Vessels; Electrocardiography; Exercise Test; Gly | 1964 |
A correlation between the inhibition of monoamine oxidase activity and the relief of angina pain by organic nitrates.
Topics: Angina Pectoris; Animals; Carbon Isotopes; Erythrityl Tetranitrate; Furans; Humans; Isosorbide Dinit | 1968 |
[Cardiac pain and its treatment with differently acting pharmacological agents in the form of a combined preparation].
Topics: Adult; Aged; Aminophylline; Angina Pectoris; Atropine; Female; Humans; Male; Middle Aged; Nitrates; | 1968 |
The use of isosorbide dinitrate in status anginosus.
Topics: Adult; Age Factors; Aged; Angina Pectoris; Electrocardiography; Female; Furans; Humans; Isosorbide D | 1970 |
[Conservative therapy of angina pectoris].
Topics: Acute Disease; Amyl Nitrite; Angina Pectoris; Anticoagulants; Coronary Disease; Digitalis Glycosides | 1970 |
Angina prophylaxis by chewable isosorbide dinitrate.
Topics: Angina Pectoris; Furans; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitrates; Tablets | 1971 |
A ten-year reevaluation. Nitroglycerin and isosorbide dinitrate in coronary insufficiency.
Topics: Aged; Angina Pectoris; Female; Furans; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitrates; Ni | 1971 |
[Inverse type of angina pectoris in a patient with long-term exposure to nitrous gases. Contribution to the paper of J. Hůla--"Atypical angina pectoris"].
Topics: Adaptation, Physiological; Angina Pectoris; Coronary Disease; Humans; Male; Middle Aged; Nitrates; N | 1972 |
Symposium on arteriosclerotic heart disease. Medical management of angina pectoris.
Topics: Acute Disease; Angina Pectoris; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Die | 1972 |
Acute coronary insufficiency. Course and follow-up.
Topics: Adult; Aged; Angina Pectoris; Aspartate Aminotransferases; Coronary Disease; Creatine Kinase; Electr | 1972 |
Developmental mechanism of angina pectoris and action of coronary vasodilators.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Electrocardiography; Exercise Test; Female; Heart Rate | 1967 |
Emotional problems in patients with angina pectoris.
Topics: Adult; Angina Pectoris; Emotions; Humans; Male; Nitrates; Physical Exertion | 1969 |
[Controlled clinical test of the antianginal action of the association of isosorbide dinitrate and prenylamine theophyllineacetate].
Topics: Acetates; Adult; Aged; Angina Pectoris; Female; Furans; Humans; Isosorbide Dinitrate; Male; Middle A | 1970 |
[Effectiveness of permanent nitrate protection (apropos of 37 cases)].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Heart Diseases; Humans; Male; Middle Aged; M | 1971 |
[Nitrates of long-term action in angina pectoris].
Topics: Angina Pectoris; Humans; Nitrates | 1967 |
[Blood histamine levels in coronary insufficiency and its dynamics under the influence of nitranole].
Topics: Adult; Aged; Angina Pectoris; Female; Heparin; Histamine; Humans; Male; Middle Aged; Myocardial Infa | 1968 |
Dilemmas of angina pectoris.
Topics: Angina Pectoris; Animals; Furans; Humans; Isosorbide Dinitrate; Nitrates; Propranolol | 1969 |
Dilemmas of angina pectoris.
Topics: Angina Pectoris; Furans; Isosorbide Dinitrate; Nitrates; Propranolol | 1969 |
Sorbide nitrate in the management of angina pectoris in general practice.
Topics: Angina Pectoris; Humans; Male; Middle Aged; Nitrates; Vasodilator Agents | 1966 |